Stockwinners Market Radar for December 06, 2017 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

OA NOC

Hot Stocks

19:29 EDT Orbital ATK receives second request from FTC for more information - Orbital ATK (OA) announced that, as expected, it has received a request for additional information from the Federal Trade Commission. This second request is part of the regulatory process in connection with the FTC's review of Northrop Grumman's (NOC) proposed acquisition of Orbital ATK. The company continues to expect the acquisition to close in the first half of 2018, after receiving regulatory approvals.
XOM

Hot Stocks

19:10 EDT Exxon Mobil and Grupo Orsan to open 50 Mobil stations in Mexico - ExxonMobil announced a partnership with retailer Grupo Orsan to open eight Mobil-branded service stations this week in Queretaro as part of the company's entry in Mexico's fuels market. ExxonMobil plans to open 50 Mobil stations in the Bajio region by the end of Q1 2018. "The opening of these first eight Mobil service stations, made possible by Mexico's new energy policy regime, is a significant milestone for the country and our company," said Carlos Rivas, fuels director for ExxonMobil Mexico. "We look forward to helping meet the country's growing demand for energy with a reliable supply of high-quality fuels and a positive customer experience."
CVX

Hot Stocks

19:01 EDT Chevron announces $18.3B capital, exploratory budget for 2018 - Chevron announced a 2018 capital and exploratory spending program of $18.3B. This figure includes $5.5B for the company's share of expenditures by affiliated companies. "Our 2018 budget is down for the fourth consecutive year, reflecting project completions, improved efficiencies, and investment high-grading," said Chairman and CEO John Watson. "We're fully funding our advantaged Permian Basin position and dedicating approximately three-quarters of our spend to projects that are expected to realize cash flow within two years." In the upstream business, approximately $8.7B is forecasted to sustain currently producing assets, including $3.3B for the Permian and $1B for other shale and tight rock investments. Approximately $5.5B of the upstream program is planned for major capital projects underway, including $3.7B associated with the Future Growth Project at the Tengiz field in Kazakhstan. Global exploration funding is expected to be about $1.1B. Remaining upstream spend will be for early stage projects supporting potential future developments. Approximately $2.2B of planned capital spending is associated with the company's downstream businesses that refine, market and transport fuels, and manufacture and distribute lubricants, additives and petrochemicals.
VLRS

Hot Stocks

18:58 EDT Volaris reports November traffic up 10.3% y/y - During November, Volaris increased total capacity, as measured in Available Seat Miles, by 11.3% year over year. Total demand, as measured in Revenue Passenger Miles in November increased 10.3% year over year, reaching 1.3B. Volaris transported a total of 1.4M passengers during the month, an increase of 9.8% year over year. Year-to-date, Volaris has transported over 14.9M passengers, an increase of 10.2% year over year. Network load factor for November was 83.9%.
CME

Hot Stocks

18:24 EDT CME Group declares annual variable dividend of $3.50 per share - CME Group declared its annual variable dividend, amounting to $3.50 per share. The dividend is payable January 15, 2018, to shareholders of record on December 28, 2017. When CME Group adopted its annual variable dividend structure in February 2012, the intention was to determine the excess cash available at the end of each year, with the level to increase or decrease from year to year based on operating results, potential investment activity and other forms of capital return. The annual variable dividend of $3.50 per share to be paid in January 2018 totals approximately $1.2B. Including the announced variable dividend and the previously announced fourth-quarter 2017 dividend of 66c per share to be paid in December, the total dividend yield for dividends announced during 2017 is 4.9% based on the average closing stock price in 2017 to date. The company will have paid a total of nearly $10B in quarterly and variable dividends since adopting the annual variable dividend structure in the beginning of 2012.
CE

Hot Stocks

18:01 EDT Celanese increases acetyl intermediates price - Celanese Corporation will increase list and off-list selling prices for acetyl intermediates products by $50 per ton. The price increases will be effective immediately.
FBMS

Hot Stocks

17:39 EDT First Bancshares acquires Sunshine Financial Community Bank for $32.1M - The First Bancshares announced the signing of an Agreement and Plan of Merger with Sunshine Financial, Inc., parent company of Sunshine Community Bank, under which First Bancshares has agreed to acquire 100% of the common stock of Sunshine in a combined stock and cash transaction. Under the terms of the Agreement and Plan of Merger, each Sunshine shareholder will have the option to receive either $27.00 in cash or 0.93 of a share of First Bancshares' common stock in exchange for each share of Sunshine common stock, subject to customary pro-ration and reallocation procedures, so that 75% of Sunshine shares will receive the stock consideration and 25% will receive the cash consideration. The aggregate consideration is valued at approximately $32.1 million, based on 1,027,599 Sunshine common shares outstanding, 80,000 Sunshine in-the money options and FBMS' stock price of $33.35 per share as of December 6, 2017. At September 30, 2017, Sunshine had approximately $194 million in assets, $161 million in loans, $142 million in deposits and $22.2 million in stockholder's equity. Sunshine Community Bank serves Leon County, Florida, through 5 locations operating in Tallahassee.
NOC OA

Hot Stocks

17:37 EDT Northrop Grumman receives FTC request for more information on Orbital ATK deal - Northrop Grumman Corporation (NOC) announced that, as expected, it has received a request for additional information from the Federal Trade Commission. This second request is part of the regulatory process in connection with the FTC's review of Northrop Grumman's proposed acquisition of Orbital ATK, Inc (OA). The company continues to expect the acquisition to close in the first half of 2018, after receiving regulatory approvals.
PAC

Hot Stocks

17:34 EDT GAP Airports reports November traffic up 11.7% - Grupo Aeroportuario del Pacifico, S.A.B. de C.V.,announced preliminary terminal passenger traffic figures for the month of November 2017, compared to traffic figures for November 2016. Total terminal passengers increased 11.7% at the company's 13 airports, compared to the same period of the previous year. Domestic passenger traffic increased by 12.3%, while international passenger traffic increased by 10.8%.
TAX

Hot Stocks

17:34 EDT Liberty Tax postpones Q2 earnings release, conference call - Liberty Tax announced the company will delay its second quarter 2018 earnings release and conference call as the company finalizes their quarterly assessment of internal controls as related to recent management changes. The company will announce the timing of the release of its second quarter fiscal 2018 results and related conference call details in the coming days.
INWK

Hot Stocks

17:33 EDT InnerWorkings CFO Jeffrey Pritchett resigns, Charles Hodgkins named interim CFO - InnerWorkings announced that Charles "Chip" Hodgkins, Senior Vice President, Corporate Development and Strategic Initiatives, has been appointed Interim CFO, effective December 6. Hodgkins' appointment to the role follows the departure of former CFO Jeffrey Pritchett, who resigned from the company, effective immediately, due to personal matters inconsistent with company policy. Pritchett's departure was not related to the company's business, operations, financial performance, or financial reporting. The company intends to undertake a search for a new CFO and will be considering both internal and external candidates.
SEAC...

Hot Stocks

17:33 EDT On The Fly: After Hours Movers - UP AFTER EARNINGS: SeaChange (SEAC), up 21.8%... Comtech (CMTL), up 18.5%... Tailored Brands (TLRD), up 14%... lululemon (LULU), up 6.3%... Okta (OKTA), up 4.2%... Broadcom (AVGO), up 3.3%. ALSO HIGHER: Digital Power (DPW), up 14.6% after it denied rumors regarding Amazon (AMZN)... Comcast (CMCSA), up 1.6% after CNBC reported that the company was still interesting in a deal with 21st Century Fox (FOXA). DOWN AFTER EARNINGS: Verint Systems (VRNT), down 7.2%... Korn/Ferry (KFY), down 4.4%... Keysight Technologies (KEYS), down 2.6%... Ollie's Bargain Outlet (OLLI), down 2.4%.
OMAB

Hot Stocks

17:33 EDT OMA Airports reports November passenger traffic up 2.3% - Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known as OMA, reports that terminal passenger traffic at its 13 airports increased 2.3% in November 2017, as compared to November 2016. Domestic traffic increased 2.5%, and international traffic increased 1.2%.
LOV

Hot Stocks

17:20 EDT Holtzbrinck Ventures reports 8.63% passive stake in Spark Networks
ABCB

Hot Stocks

17:14 EDT Ameris Bancorp names Dennis J. Zember Jr. CEO - Ameris Bancorp, the parent company of Ameris Bank, announced promotions on its executive team. Effective as of January 1, 2018, Edwin W. Hortman, Jr. will be succeeded as CEO of Ameris Bank by Dennis J. Zember Jr., previously executive VP, CFO and COO of the company and executive VP and COO of Ameris Bank. From February 2005 until June 2016, Zember also served as Chief Financial Officer of Ameris Bank. Zember will continue to serve as executive VP and COO of the company. Together with these changes, the company announced that Nicole S. Stokes has been promoted to executive VP and CFO of the company and Ameris Bank effective January 1, 2018. Stokes joined the company in December 2010 as Controller and was previously promoted to Senior Vice President and Chief Financial Officer of Ameris Bank in June 2016.
ADVM

Hot Stocks

17:06 EDT Highbridge Capital reports 5.55% passive stake in Adverum Biotechnologies
WAC

Hot Stocks

17:05 EDT Walter Investment names Jeff Baker as COO, effective immediately - In this role, Baker will expand his duties beyond President of RMS and assume responsibility for Ditech Financial LLC's performing and default servicing operations. Jeffrey Baker has served as President of RMS since October 2016. He served in various other capacities for the company from July 2015 to October 2016.
WAC JPM

Hot Stocks

17:04 EDT Walter Investment announces Jerry Lombardo to succeed Gary Tillett as CFO - Walter Investment (WAC) announced that Jerry Lombardo, a seasoned financial executive with over 25 years of experience, has agreed to join the company to succeed Gary Tillett as CFO. Tillett, Executive Vice President and CFO, will retire in 2018. Lombardo most recently served as a Managing Director & Treasurer of the Consumer and Community Bank at JP Morgan Chase & Co. (JPM).
MRK

Hot Stocks

17:03 EDT Merck: NE Journal publishes main results of Prevymis study - Merck announced that the New England Journal of Medicine has published online the main results from the pivotal Phase 3 clinical study of PREVYMIS, the company's new medicine for prophylaxis of cytomegalovirus infection and disease in adult CMV-seropositive recipients of an allogeneic hematopoietic stem cell transplant. The paper will also appear in a forthcoming print issue of the journal. CMV-seropositive patients who undergo allogeneic hematopoietic-cell transplantation are at high risk for CMV reactivation. CMV infection is a common clinically significant complication in these patients and early CMV reactivation after transplant is associated with increased mortality. PREVYMIS is a first-in-class antiviral drug that inhibits CMV replication. "This study culminates more than a decade of efforts to identify new, highly effective antiviral medicines for patients that can be prescribed prophylactically after hematopoietic-cell transplantation," said Dr. Francisco M. Marty, associate professor of medicine at Harvard Medical School and attending physician in transplant and oncology infectious diseases at Dana-Farber Cancer Institute and Brigham and Women's Hospital. In the study, significantly fewer patients in the PREVYMIS arm compared to the placebo arm developed clinically significant CMV infection, discontinued treatment or had missing data through Week 24 post-transplant, the primary efficacy endpoint. The treatment effect for PREVYMIS in preventing clinically significant CMV infection was consistent across pre-specified high- and low-risk strata for CMV reactivation both at Week 14 and at Week 24 post-transplant. All-cause mortality in patients receiving PREVYMIS was lower compared to placebo at Week 24 post-transplant and at Week 48 post-transplant.
ONCE PFE

Hot Stocks

17:03 EDT Spark Therapeutics and Pfizer publish interim gene therapy data in NEJM - Spark Therapeutics (ONCE) and Pfizer (PFE), announced that The New England Journal of Medicine has published interim data as of July 25, 2017, from the Phase 1/2 clinical trial of SPK-9001, an investigational gene therapy for hemophilia B. With a cumulative follow-up of 492 weeks' observation of the first 10 adult male participants, the mean steady-state factor IX activity was 34 percent of normal (range of 14-81 percent) following a single administration of investigational SPK-9001. The annualized bleeding rate was reduced 97%, from a mean rate of 11.1 events per year before vector administration to 0.4 events per year after vector administration, while factor IX concentrate use was reduced 99%. In this open-label, non-randomized, multicenter Phase 1/2 clinical trial, there were no serious adverse events during or following infusion of SPK-9001, and no participants experienced thrombotic events or developed factor IX inhibitors. Two participants developed an asymptomatic and transient increase in liver enzymes that resolved with a tapering dose of oral corticosteroids. One participant with severe joint disease has administered factor for suspected bleeding, but overall factor use for this participant was 91% lower than before SPK-9001 infusion.
BKJ

Hot Stocks

17:01 EDT Bancorp of New Jersey declares special cash dividend of 10c per share - Payable on December 27 to stockholders of record as of the close of business on December 19. "The Board of Directors is pleased to announce a special cash dividend of $0.10 per common share. Our strategy calls for ongoing reinvestment to support the growth of our business, however from time to time we will look to return capital to our valued shareholders," said Nancy Graves, Bancorp of New Jersey's President and CEO. "While we do not expect to resume the payment of a regular quarterly dividend, we do believe that a special dividend is consistent with our sound capital management policies and our commitment to providing a meaningful return to our stockholders."
OKTA KRC

Hot Stocks

16:57 EDT Okta signs 10-year lease on new HQ in San Francisco with Kilroy Realty - Kilroy Realty Corporation (KRC) today said it has signed a 10-year lease with Okta (OKTA) for 207,000 square feet of space at Kilroy Realty's 100 First Street office property in the South of Market district of San Francisco. A leading provider of identity for the enterprise, Okta is expanding its footprint in the city in the wake of its April 2017 initial public offering and anticipated growth plans. Okta plans to establish its new corporate headquarters at 100 First Street, with expected occupancy occurring in phases, beginning in the second quarter of 2018.
NYRT

Hot Stocks

16:56 EDT New York REIT to issue $1.00 per share cash liquidating distribution - York REIT, which is liquidating and winding down pursuant to a plan of liquidation, announced the company's Board of Directors has declared a cash liquidating distribution of $1.00 per share to be paid on December 27 to shareholders of record as of December 18. The liquidating distribution is being paid from the net proceeds from recent property sales.
DOX

Hot Stocks

16:54 EDT Amdocs to invest up to $350M on new campus in Israel - Amdocs announced it has signed an agreement with Union Group to partner for the purchase of the land for its future campus in Ra'anana, Israel. The transaction for the acquisition of the land is expected to be completed in the near term upon satisfaction of customary closing conditions. The total net investment that Amdocs expects to make in connection with the purchase of the land and the construction of the new campus is expected to reach up to $350 million over a period of four to five years, and is expected to be financed by internal cash resources. As previously disclosed, this investment includes incremental capital expenditure of up to $100 million in fiscal year 2018. Excluding this incremental capital expenditure, Amdocs expects to generate free cash flow of roughly $500 million in fiscal year 2018, of which it plans to return approximately 100% to shareholders through its ongoing share repurchases and dividend program for the full year.
UHT

Hot Stocks

16:47 EDT Universal Health Realty raises quarterly dividend by 0.5c to 66.5c - Dividend payable on December 29, 2017 to shareholders of record as of December 18, 2017.
WPC

Hot Stocks

16:46 EDT W.P. Carey raises quarterly dividend to $1.01 per share - The dividend is payable on January 16, 2018 to stockholders of record as of December 29, 2017.
DECK

Hot Stocks

16:40 EDT Egan Jones recommends shareholders vote 'FOR' all Deckers' director nominees - Deckers Brands announced that leading independent proxy advisory firm Egan-Jones Ratings Company has joined Glass Lewis & Co. in recommending that stockholders vote "FOR" ALL of Deckers' highly-qualified and experienced director nominees at the 2017 Annual Meeting of Stockholders to be held on December 14.
FLR

Hot Stocks

16:39 EDT Fluor awarded $495M Puerto Rico electric grid contract - Fluor Corporation announced that the company was awarded a second task order under its contract with the U.S. Army Corps of Engineers Huntsville Engineering Center to assist with the restoration and rebuilding of transmission and distribution lines in Puerto Rico. The competitively awarded contract includes evaluation, restoration, repair and replacement of structures and equipment supporting the electrical infrastructure of the island. Fluor has been awarded a second task order to assist with the restoration and rebuilding of transmission and distribution lines in Puerto Rico. The three-month single award task order is funded at $495 million with a ceiling of $831 million and is the second awarded to Fluor for power restoration work in Puerto Rico. A previous task order for $240 million was awarded on October 16, 2017, with an additional $261 million being added to the original task order on December 4, 2017. Both task orders represent work assigned to the Corps under a Federal Emergency Management Agency mission.
MED

Hot Stocks

16:33 EDT Medifast increases quarterly dividend 50% - Medifast announced that its board has declared a 48c cash dividend to its stockholders, reflecting a 16c or 50% increase over the previous quarter's cash dividend. The quarterly cash dividend is payable on February 8, 2018 to stockholders of record as of the close of business on December 22, 2017.
RUN

Hot Stocks

16:33 EDT Sunrun COO Paul Winnowski to retire, Christopher Dawson to succeed - Sunrun announced leadership changes. Paul Winnowski, President and COO, will retire from the company in early 2018. Christopher Dawson will join Sunrun as COO effective immediately. Dawson spent the majority of his career with Bombardier Recreational Products Inc., a leading powersports vehicle manufacturer.
EW

Hot Stocks

16:31 EDT Edwards Lifesciences acquires Harpoon Medical - Edwards Lifesciences announced the acquisition of Harpoon Medical, a privately held medical technology company pioneering beating-heart repair for degenerative mitral regurgitation. Edwards announced a structured upfront investment in Harpoon in 2015, with an exclusive option to acquire the company. Under the terms of the merger agreement, Edwards paid $100M in cash for Harpoon at closing on Dec. 1. In addition, there is the potential for up to $150M in pre-specified milestone-driven payments over the next 10 years. The HARPOON system is designed to facilitate echo-guided repair of mitral valve regurgitation, by stabilizing the prolapsed mitral valve leaflet to restore proper coaptation and valve function. The HARPOON device is currently investigational and not available for commercial use. It is expected to receive CE Mark approval soon.
TLRD

Hot Stocks

16:29 EDT Tailored Brands up 11% to $19.10 after Q3 results beat estimates
DPW AMZN

Hot Stocks

16:27 EDT Digital Power denies rumors regarding Amazon.com - Digital Power Corporation (DPW) stated that it has entered into no agreement and has received no order from Amazon (AMZN). DPW further avers it is not negotiating anything with Amazon. The company was informed of a rumored deal between DPW and Amazon in the amount of $450M for hardware related to cryptocurrency. While DPW has made moves towards entering the cryptocurrency and digital mining spaces and has disclosed its activities in recent press releases and will continue to do so, DPW categorically denies the validity and accuracy of any such rumors. DPW cautions its investors and all other persons not to rely on rumors or statements made by any person or entity other than DPW itself or its authorized representatives.
SEAC

Hot Stocks

16:23 EDT SeaChange up 25% afterhours to $3.50 following Q3 results and FY18 raise
TLRD

Hot Stocks

16:22 EDT Tailored Brands reports inventories down 7.1% to $973M at Q3-end
OLLI

Hot Stocks

16:21 EDT Ollie's Bargain Outlet down 4.9% to $48.50 after Q3 results and FY17 outlook
TLRD

Hot Stocks

16:17 EDT Tailored Brands reports Q3 Men's Wearhouse SSS down 1.0% - For the third quarter of 2017, total net sales decreased 4.3% to $810.8 million. Retail net sales decreased 2.1% primarily due to the impact of last year's store closures, with retail segment comparable sales up 0.1%. Corporate apparel net sales decreased 24.0%, in line with expectations, primarily due to anniversarying last year's rollout of a large new uniform program. Comparable sales at Men's Wearhouse decreased 1.0%. Comparable sales for clothing increased slightly primarily due to an increase in transactions and units per transaction partially offset by a decrease in average unit retail. Comparable rental services revenue decreased 4.3%, primarily reflecting a consumer shift to purchase suits for special occasions. Jos. A. Bank comparable sales increased 4.9% primarily due to an increase in transactions and average unit retail that more than offset a decrease in units per transaction. K&G comparable sales decreased 0.6% primarily due to lower transactions partially offset by increases in average unit retail and units per transaction. Moores comparable sales decreased 2.6% primarily due to decreases in both units per transaction and transactions that more than offset an increase in average unit retail.
AVGO

Hot Stocks

16:16 EDT Broadcom down over 1% after reporting Q4 earnings, giving Q1 guidance
LULU

Hot Stocks

16:15 EDT lululemon up 6% after earnings beat, guidance raise
AVGO

Hot Stocks

16:15 EDT Broadcom raises quarterly interim dividend 72% from prior quarter - Broadcom's board has approved a quarterly, interim cash dividend of $1.75 per ordinary share. A corresponding distribution will also be paid by the partnership, of which the company is the general partner, to holders of REUs, in the amount of $1.75 per REU. The dividend and the distribution are both payable on December 29 to shareholders or unitholders of record on December 19, 2017.
OKTA

Hot Stocks

16:12 EDT Okta announces customer wins, expanded deployments in Q3 - Okta announced that new 3Q18 customers CBRE, City of Las Vegas, Nordstrom and State of Arizona have chosen the Okta Identity Cloud to securely connect their people and technology. In addition, the company announced expanded deployments with Caesars Entertainment, Eventbrite, Flight Centre, Groupon and Restoration Hardware. "For years, we've said that every company has to become a technology company to survive and thrive in the new cloud and mobile world. Today, retailers are moving quickly to the cloud to compete with Amazon.com, cities are finding new ways to engage with citizens online, and hospitality leaders are utilizing technology to revolutionize the way they interact with guests. Organizations of all sizes and in every industry are either adopting or building new technologies to better connect their employees, partners, customers and constituents," said Todd McKinnon, Okta CEO and co-founder. "We're thrilled that industry-leading organizations like Nordstrom, City of Las Vegas and Caesars Entertainment chose the Okta Identity Cloud as the foundation from which to drive these initiatives forward, and we look forward to making them successful."
LULU

Hot Stocks

16:12 EDT lululemon CEO 'energized' by momentum reflected in raised guidance - Laurent Potdevin, CEO, lululemon, said: "Our teams powerfully delivered robust results across both store and digital channels this quarter, driving a further acceleration in our business. The strength of our Q3 earnings supports our unique position as the global brand defining an active, mindful lifestyle. As we start the holiday season, I'm energized by our momentum and we are increasing guidance to reflect this performance. I'm grateful for the enthusiasm I see every day across our collective as we remain on our path to delivering $4 billion in revenue in 2020."
LXU

Hot Stocks

16:11 EDT LSB Industries: Pryor, OK facility resumes production - LSB Industries announced that the ammonia plant at its Pryor, Oklahoma chemical facility resumed production on December 4, 2017. As previously announced, Pryor was taken out of service to repair damage to some of the ammonia plant's electrical controls, wiring and piping resulting from a fire that occurred on September 23, 2017. Management expects that the EBITDA impact resulting from the expenses related to the repairs and to upgrades made to reduce pipe stress that will enable Pryor to skip its planned 2018 turnaround, the excess cost of purchasing UAN versus producing it in order to meet customer commitments, and the reduced absorption of fixed costs will be between $5.5M and $6M for the fourth quarter of 2017.
LULU

Hot Stocks

16:11 EDT lululemon authorizes $200M stock repurchase program - lululemon announced that its board of directors has approved a new stock repurchase program for up to $200M of its common shares in the open market at prevailing market prices, including under plans complying with the provisions of Rule 10b5-1 and Rule 10b-18 of the Securities Exchange Act of 1934.
AGN

Hot Stocks

16:05 EDT Allergan CEO voices 'absolute conviction' in company - Allergan CEO Brent Saunders, in reply to a tweet from CNBC's Jim Cramer regarding the purchase of company shares disclosed earlier by the executive, tweeted: "Absolute conviction in @Allergan, our business, people and future! #boldforlife" Reference Link
SSKN

Hot Stocks

16:04 EDT Strata Skin Sciences announces departure of CFO Christina Allgeier - STRATA Skin Sciences announced that Christina Allgeier resigned as CFO to pursue other opportunities. Allgeier intends to remain in her current role through December 31. Allgeier has agreed to assist the company during the transition period as it searches for a new CFO by entering into a transition services agreement, under which she will provide STRATA with consulting services through March 31, 2018.
OSIS

Hot Stocks

15:51 EDT OSI addresses security inspection programs after Muddy Waters report - OSI Systems issued a statement in response to a report this morning by short-sellers Muddy Waters Research. OSI said, "While the Company would not customarily respond to misleading allegations from short sellers, this particular report has had an undue impact in the public sphere and warrants a response. We begin by noting that our turnkey security inspection programs in Mexico and in Albania were the result of public tenders. Both have resulted in enhanced security, increased seizures of contraband, and improved transparency in customs declarations, significantly benefiting both countries. Our Albania turnkey security inspection program is operated in partnership with ICMS, a local company with civil works construction capabilities in Albania, with a profit share in accordance with the terms of our agreement with ICMS. ICMS implemented all civil works construction for the program. As such, both we and ICMS made significant capital investments toward the implementation of the program in a value well beyond the par value of shares. Our Mexico turnkey security inspection program operates security inspection checkpoints at multiple critical sites across Mexico as designated by the government. The program has resulted in significant seizures of high-value contraband. The Company has previously stated that we are in discussions with the government towards the extension of the program under a reduced revenue rate." Following Muddy Waters' short report and video this morning, shares of OSI are down 29%, or $24.01, to $60.06.
OSIS

Hot Stocks

15:48 EDT OSI Systems calls Muddy Waters' allegations 'misleading'
GD

Hot Stocks

15:42 EDT General Dynamics unit awarded $432M U.S. Navy contract - General Dynamics Electric Boat has been awarded a $432M contract modification by the U.S. Navy to provide research and development and lead-yard services for Virginia-class nuclear-powered attack submarines. Electric Boat is a wholly owned subsidiary of General Dynamics. Under the contract, Electric Boat will undertake development studies and other work related to Virginia-class submarine design improvements. Additionally, Electric Boat will perform research and development work required to evaluate new technologies to be inserted in newly built Virginia-class ships, including the Virginia Payload Module. Initially awarded in August 2016, the contract has a potential value of $900M through November 2018. This work will engage Electric Boat's engineering and design organization, which comprises more than 5,000 employees. Possessing proven technical capabilities, these employees work on all facets of the submarine life cycle from concept formulation and design through construction, maintenance and modernization, and eventually to inactivation and disposal.
VSAT

Hot Stocks

15:35 EDT ViaSat, Air Force complete production readiness review on Mini Crypto - The U.S. Air Force, in partnership with Viasat, announced earlier today the successful completion of its production readiness review on the Mini Crypto program for the development of an embeddable cryptographic security/data module for military handheld devices and unmanned systems that communicates sensitive and classified data. "By passing PRR, the U.S. Air Force and Viasat will proceed into Low Rate Initial Production (LRIP). The Viasat Mini Crypto module will enable U.S. Air Force and military personnel to procure affordable small form factor embeddable encryption devices," the statement read. Viasat calls its Mini Crypto module a "new breakthrough in technology for securing U.S. Air Force's small form factor unmanned systems and sensors that transmit SECRET and Below (SAB) data."
AKS

Hot Stocks

15:32 EDT AK Steel 'applauds' U.S. Department of Commerce ruling on Chinese steel - AK Steel said that it strongly supports the preliminary rulings by the Department of Commerce in the circumvention investigations concerning imports of certain cold rolled and corrosion-resistant flat-rolled steel that originated in China, and was then finished in Vietnam and shipped into the United States. U.S. Customs and Border Protection will collect anti-dumping duties of 265.79% and countervailing duties of 256.44% on cold rolled steel, and duties of 199.43% and 39.05%, respectively, on corrosion-resistant steel, for all shipments that entered the U.S. beginning November 4, 2016. Roger Newport, CEO of AK Steel, said, "We commend the Commerce Department for holding these parties accountable and for sending a signal to foreign producers and countries around the world that the U.S. will vigorously enforce its laws without exception. We encourage the Commerce Department and the Administration to continue these positive efforts with swift and broad action on the Section 232 investigation on steel imports."
NMRX SWIR

Hot Stocks

15:28 EDT Numerex announces shareholder approval of merger agreement - Numerex Corp. (NMRX) announced that, at its special meeting of shareholders held today, a majority of the votes cast, which also represented a majority of the outstanding shares of the company's common stock, voted to approve the adoption of the previously announced Agreement and Plan of Merger, dated as of August 2, 2017, by and among the company, Sierra Wireless, Inc. (SWIR) and Wireless Acquisition Sub, Inc. Upon completion of the merger, Numerex shareholders will receive a fixed exchange ratio of 0.1800 common shares of Sierra Wireless for each share of Numerex common stock. Subject to the satisfaction of the remaining closing conditions, the company, Sierra Wireless and Merger Sub currently anticipate to close the merger on December 7, 2017.
GILD

Hot Stocks

15:26 EDT Gilead not commenting on notice posted to FTC site regarding deal - Following posting of notice of allowance of transaction on the Federal Trade Commission site, a spokesperson for Gilead told The Fly that the company does not "have a comment" at this moment.
MGTI

Hot Stocks

15:13 EDT MGT Capital Investments announces purchase of 500 additional mining rigs - MGT Capital Investments announced that it has executed a new purchase order with Bitmain Technologies for an additional 500 S9 Antminer mining rigs, with shipment expected early in the first quarter of 2018. Following shipment and setup, and in conjunction with the company's current rigs in operation or in its possession, MGT's Bitcoin mining operations will be comprised of over 5,000 Bitmain S9's. The company expects all rigs announced to date to be operating during the first quarter of 2018. "These machines are expected to generate roughly 70 Ph/s of total hash power, and over $4 Min monthly revenue, assuming current Bitcoin pricing and Difficulty rates," MGT Capital stated.
PBYI

Hot Stocks

15:11 EDT Puma Biotechnology reports interim results of Phase 2 CONTROL trial - Puma Biotechnology announced it will present updated interim results from a Phase 2 clinical trial of Puma's drug neratinib at the 2017 San Antonio Breast Cancer Symposium that is currently taking place. The presentation entitled, "Effects of adding budesonide or colestipol to loperamide prophylaxis on neratinib-associated diarrhea in patients with HER2-positive early stage breast cancer: the CONTROL trial," will be presented at a poster session on December 7. The main adverse event seen to date in clinical trials of neratinib is diarrhea and, more specifically, grade 3 diarrhea. In the Phase III ExteNET trial of neratinib as extended adjuvant treatment of HER2-positive early stage breast cancer that has previously been treated with adjuvant Herceptin, 95.4% of the patients experienced all grade diarrhea and 39.8% of the patients experienced grade 3 or higher diarrhea. There was one event of grade 4 diarrhea. The interim analysis of the trial presented in the poster included a total of 137 patients who received neratinib plus loperamide prophylaxis, 64 patients who received neratinib plus loperamide prophylaxis for 2 cycles and budesonide for 1 cycle, and 120 patients who received neratinib plus loperamide prophylaxis for 1 cycle and colestipol for 1 cycle. The results of the trial showed that the incidence of grade 3 diarrhea for the 137 patients who received the loperamide prophylaxis was 30.7%. For the 137 patients who received the loperamide prophylaxis, the median number of grade 3 diarrhea episodes per patient was 1 and the median cumulative duration of grade 3 diarrhea was 3 days. For the 137 patients who received loperamide prophylaxis, 20.4% discontinued neratinib due to diarrhea. For the 64 patients who received the combination of loperamide plus budesonide, the results of the trial showed that the incidence of grade 3 diarrhea was 26.6%. The median number of grade 3 diarrhea episodes per patient was 1 and the median cumulative duration of grade 3 diarrhea was 2 days. For the 64 patients who received loperamide plus budesonide prophylaxis, 10.9% discontinued neratinib due to diarrhea. For the 120 patients who received the combination of loperamide plus colestipol, the results of the trial showed that the incidence of grade 3 diarrhea was 10.8%. The median number of grade 3 diarrhea episodes per patient was 1 and the median cumulative duration of grade 3 diarrhea was 3 days. For the 120 patients who received loperamide plus colestipol prophylaxis, 1.7% discontinued neratinib due to diarrhea.
AMZN...

Hot Stocks

15:06 EDT Roku continues to rise as YouTube, Amazon fight escalates - Shares of Roku (ROKU) are on the rise amid reports that Google (GOOG; GOOGL) is pulling its YouTube service from Amazon (AMZN) FireTV. GOOGLE PULLING YOUTUBE FROM FIRETV: Yesterday, CNET reported that Google was pulling its YouTube service from Amazon's FireTV and Echo Show. A spokesperson for Google told the tech website: "We've been trying to reach agreement with Amazon to give consumers access to each other's products and services. But Amazon doesn't carry Google products like Chromecast and Google Home, doesn't make Prime Video available for Google Cast users, and last month stopped selling some of Nest's latest products. Given this lack of reciprocity, we are no longer supporting YouTube on Echo Show and FireTV. We hope we can reach an agreement to resolve these issues soon." YouTube will no longer be accessible via the Amazon devices on January 1, the report said. Roku's "agnostic" streaming devices allow access to subscribers of Google, Netflix (NFLX), Apple (AAPL) and Amazon media services. PRICE ACTION: In afternoon trading, shares of Roku have jumped about 9% to $42.91. Roku shares are up dramatically since the IPO of the company's stock in September. On September 28, Roku opened at $15.78 in its first day of trading on the Nasdaq after its initial public offering was priced at $14 per share. The streaming media device maker closed that day at $23.50.
XOM

Hot Stocks

14:46 EDT Exxon Mobil exec Spellings sells 9,379 common shares - In a regulatory filing, Exxon Mobil vice president and general tax counsel James M. Spellings, Jr. disclosed the sale of 9,379 common shares of the company at a price of $83.365 per share.
SAM...

Hot Stocks

14:28 EDT Craft beer still seen taking alcohol share despite growth slowdown - Commenting on the craft beer and beverage sector, Stifel analyst Mark Swartzberg told investors that craft beer continues to take alcohol share despite growth slowing down, while craft spirits sales are growing faster than craft beer sales in their infancy. Given competition and current valuation, the analyst initiated coverage of Boston Beer (SAM), Craft Brew Alliance (BREW) and MGP Ingredients (MPGI) with a Hold rating. CRAFT BEER AND SPIRITS: In a research note to investors, Stifel's Swartzberg pointed out that the craft beer category has exhibited considerable growth over the last decade, but noted that heightened competitive intensity is eroding leading craft brewer shares. Craft beer growth has slowed but continues to take alcohol share, while craft spirits sales are growing faster than craft beer sales in their infancy, he contended, adding that he sees craft spirits having "considerable runway" and fuel for growth. Swartzberg pointed out that craft beer's largest participants are increasingly focused on a portfolio approach to national presence, focusing especially on localities and regions for a given craft brewery's growth. He believes AB InBev (BUD) is the best positioned among the U.S.'s four largest strategics to continue this strategy and expects private equity participants to remain active but restrained in the segment too. BOSTON BEER TAKEOUT UNLIKELY: Stifel's Swartzberg started coverage of Boston Beer with a Hold rating and $166 price target saying that while momentum argues against a Sell recommendation, the shares are expensive since a takeout is unlikely, improving trends could be fleeting, and brewing utilization pressures margins as volumes weaken. The analyst is also concerned the company's brewing footprint is too big. Additionally, Swartzberg noted that a CEO change seemingly compounds risk of fundamental disappointment if improvement is short-lived, but he thinks CEO Martin Roper's intent to stay until February 2018, or such later date as he and his successor agree, demonstrates his commitment to the next CEO's effectiveness. CRAFT BREW FUTURE UNCERTAIN: The analyst also started coverage of Craft Brew Alliance with a Hold rating and $19 price target saying that an AB InBev offer for the company is not entirely probable, given that it is not dependent on Craft Brew to execute its craft strategy and a deal may be not be possible either due to Craft Brew's desire to remain independent or to the July 2016 consent decree between AB InBev and the U.S. Department of Justice. Swartzberg noted that Craft Brew entered into a set of commercial arrangements with AB InBev, and added that he believes the former is amenable to an offer by the latter, given the implied premium and the likelihood that foregone AB InBev agreements compound the category headwinds that Craft Brew currently faces. EXPECTATIONS FOR MGP TOO HIGH: Stifel's Swartzberg also started coverage of MGP Ingredients, a producer and supplier of distilled spirits including bourbon and rye whiskeys, vodka and gin, with a Hold rating and $73 price target. Growth expectations are up a lot this year, making it difficult to keep outperforming, he said. Nonetheless, he thinks the market is right to expect more high single-digit growth with major improvements in margins and cash flow. PRICE ACTION: In afternoon trading, shares of Boston Beer have gained about 1% to $186.40, and MGP Ingredients is flat at $74.86. Meanwhile, Craft Brew has dropped 3% to $18.95.
OSIS

Hot Stocks

14:08 EDT OSI Systems shares now down 30%, or $25.72 to $58.35
SYK

Hot Stocks

14:04 EDT Stryker increases dividend 11% to 47c per share - Stryker announced that its board of directors has declared a quarterly dividend of 47c per share payable on January 31, 2018 to shareholders of record at the close of business on December 29, 2017, representing an increase of approximately 11% versus the prior year and the previous quarter.
RSLS

Hot Stocks

14:03 EDT ReShape Lifesciences to be granted patent in EU - EnteroMedics (ETRM) previously announced that the company had formally changed its name to ReShape Lifesciences (RSLS), effective October 23. The European Patent Office intends to grant the company a patent for safety features for use in medical devices, according to a post to its website dated November 29. Reference Link
GILD

Hot Stocks

13:41 EDT Gilead granted FTC early termination for deal with Cell Design Labs - According to a notice posted to the Federal Trade Commission website, Gilead was granted early termination for its acquisition deal with Cell Design Labs. The notice identifies Gilead as the "Acquiring Party" and Cell Design as the "Acquired Party" but does not give further detail on the nature or terms of the transaction. Reference Link
NVS

Hot Stocks

13:17 EDT Novartis says Kisqali median PFS superior to oral endocrine therapy in trial - Novartis announced results from the Phase 3 MONALEESA-7 trial in premenopausal or perimenopausal women with hormone-receptor positive, human epidermal growth factor receptor-2 negative advanced or metastatic breast cancer demonstrating Kisqali in combination with an aromatase inhibitor or tamoxifen and goserelin as initial endocrine-based therapy significantly prolonged progression-free survival compared to endocrine therapy and goserelin alone. Kisqali in combination with tamoxifen or an aromatase inhibitor plus goserelin demonstrated a median PFS of 23.8 months compared to 13.0 months for tamoxifen or an aromatase inhibitor plus goserelin. Premenopausal women treated with Kisqali combination therapy saw a response as early as eight weeks as demonstrated by separation of the PFS curves compared to endocrine therapy alone, the company added. These data will be presented today as a late-breaker oral presentation at the 2017 San Antonio Breast Cancer Symposium.
FNJN

Hot Stocks

13:04 EDT Finjan Holdings files patent infringement complaint against Zscaler - Finjan Holdings announced that -- after more than one year of good faith efforts to resolve a patent dispute with Zscaler -- its subsidiary Finjan, Inc. has filed a patent infringement lawsuit against Zscaler, a Delaware company. Finjan filed a complaint on December 5, and alleges that Zscaler's products and services infringe at least four U.S. Finjan patents. Finjan is seeking, among other things, a jury trial, past damages not less than a reasonable royalty, enhanced damages for willful infringement, and reasonable attorneys' fees and costs for infringement of each of the asserted patents, as well as preliminary and permanent injunctive relief from continuing to infringe the '633 and '305 Patents.
SPR

Hot Stocks

13:02 EDT Spirit AeroSystems plans Wichita expansion, to add 1,000 jobs over five years - Spirit AeroSystems announced plans for major expansion and growth, including the addition of 1,000 jobs and capital investments totaling $1B over the next five years at its Wichita, Kan., facility. The growth is fueled by a number of factors: increasing production rates on existing commercial aircraft programs, growth in Spirit's Fabrication and Defense businesses and other new business pursuits. The announcement solidifies Spirit's presence in Wichita and Kansas for decades to come. "Wichita is our headquarters and the hub of our operations," said Spirit President and CEO Tom Gentile. "Our workforce is unparalleled, with generations of aircraft employees who have worked in our plant. And now future generations will have those same opportunities. We are proud to partner with the city, county and state to bring new jobs and investment to the community and help ensure Wichita remains the Air Capital of the World."
OSIS

Hot Stocks

12:50 EDT OSI Systems down 21% to $66.38 after Muddy Waters short call
CSGS

Hot Stocks

12:44 EDT CSG Systems CFO Wiese sells 19,225 shares - CSG Systems CFO Randy Wiese disclosed the sale of 19,225 shares at a price of $44.41. Wiese continues to own 103,506 shares of CSG Systems.
AGN

Hot Stocks

12:37 EDT Allergan CEO Saunders buys 4,600 shares - Allergan CEO Brent Saunders disclosed in a regulatory filing the purchase today of 4,600 shares at prices of $164.71 and $165.35. The CEO now owns 186,377 shares of Allergan.
BDC

Hot Stocks

12:29 EDT Analysts remain bullish on Belden following investor day - Shares of Belden (BDC) were in focus following the company's Investor Day presentation yesterday, during which the networking and connectivity products manufacturer reiterated its guidance for the fourth quarter and fiscal 2017 and provided fiscal 2018 guidance that was roughly in line with analyst estimates. Following the presentation, several firms maintained Buy ratings on the stock, with Stifel also raising its price target on the shares. WHAT'S NEW: In a press release ahead of its Investor Day on Tuesday, Belden backed its outlook for Q4 and FY17. The company continues to see Q4 adjusted EPS in a range of $1.71-$1.81 on revenue of $641M-$661M, compared to the consensus views of $1.76 and $648.36M, respectively, and still sees FY17 adjusted EPS of $5.45-$5.55 on revenue of $2.425B-$2.44B, compared to the consensus views of $5.50 and $2.43B, respectively. During the presentation, Belden also guided for FY18 adjusted EPS of $5.95-$6.20 on revenue of $2.492B-$2.542B, compared to analysts' estimates for $6.08 and $2.52B, respectively. The FY18 guidance assumes organic growth of 1%-3% and no impact from any 2018 M&A and share repurchases, the company noted. In addition, Belden provided three-year goals, forecasting a total revenue growth CAGR of 5%-7%, an EBITDA margin of 20%-22% and a free cash flow CAGR of 13%-15% from 2017-2020. STREET RESEARCH: Following Belden's investor day, Stifel analyst Noelle Dilts maintained a Buy rating on the stock and raised her price target on the shares to $97 from $90, saying that the initial 2018 guidance was relatively in-line with consensus. Dilts added that the overall presentation was supportive of the pillars of her firm's investment thesis: Improved organic growth in 2018, continued margin improvement and "bolt-on" M&A activity. In addition, Goldman Sachs analyst Mark Delaney also backed his Buy rating on Belden with a $91 price target on the shares, saying that the company continues to be "well positioned" to benefit from improving growth. The analyst also noted that the FY18 revenue guidance is "conservative" considering that the company has historically executed on its tuck-in M&A strategy and M&A contribution is excluded from the guidance. Canaccord also weighed in after the Investor Day, reaffirming its Buy rating on the stock with a $94 price target. PRICE ACTION: In afternoon trading, shares of Belden are up 0.3% to $82.79.
AAPL...

Hot Stocks

12:15 EDT Apple suppliers dragged down by Largan revenue warning on weak orders - Apple (AAPL) iPhone camera lens maker Largan Precision warned that the company's revenue in December will fall versus the previous month, according to media reports. The news seems to have raised concerns regarding Apple's orders ahead of the holidays, with Skyworks (SWKS), Cirrus Logic (CRUS), Broadcom (AVGO), and Qorvo (QRVO) all sliding in afternoon trading. DROP IN ORDERS: Largan Precision has warned that its revenue is expected to fall in December, versus the previous month, during a traditionally strong period for iPhone shipments, according to the Nikkei Asian Review. Citing Taiwan's Economic Daily News, the publication says the company's December weakness comes from a drop in orders from some customers, but did not specify which ones. Largan supplies lenses for all Apple iPhone models and for the new iPhone X's Face ID module. OTHERS TO WATCH: Several Apple suppliers are slipping in afternoon trading. Shares of Skyworks and Broadcom have dropped almost 1%, Cirrus Logic's stock has slipped about 2%, and shares of Qorvo have slid over 3%. Reference Link
IMMU

Hot Stocks

12:13 EDT Immunomedics reports ORR of 31% in IMMU-132 trial in mTN breast cancer patients - Immunomedics announced that a blinded, independent review by an adjudication team of radiologists has determined an ORR of 31%, including six complete responses and 28 partial responses, in 110 patients with metastatic triple-negative breast cancer, or mTNBC, after receiving treatment with sacituzumab govitecan, the company's lead investigational antibody-drug conjugate, in a Phase 2 study. The independent centrally-reviewed median DOR was 9.1 months. Michael Pehl, President and CEO-elect of Immunomedics, stated, "We believe the blinded independent adjudication affirms the significant clinical activity of sacituzumab govitecan as a single agent in the third-line setting for patients with relapsed or refractory mTNBC. We remain focused on bringing this important medicine to breast cancer patients expeditiously and on transforming Immunomedics into a fully integrated biopharmaceutical company, creating value for our stockholders. To that end, the completion of this Phase 2 study is the second major step in our preparation of a BLA to be submitted to the FDA for accelerated approval of sacituzumab govitecan in this very aggressive form of cancer." The company added: "These encouraging results will be part of a BLA package anticipated to be submitted in the first quarter of 2018 to the FDA for accelerated approval of sacituzumab govitecan as a third-line treatment for patients with mTNBC."
IMMU

Hot Stocks

12:09 EDT Immunomedics jumps 12% with data being presented at cancer symposium - Shares of Immunomedics have jumped $1.09, or 12%, in midday trading to $10.12 as the company is scheduled to be presenting at the San Antonio Breast Cancer Symposium. Immunomedics previously announced that it would be presenting data on sacituzumab govitecan, an anti-Trop-2-SN-38 antibody-drug conjugate, as greater than or equal to3rd-line therapeutic option for patients with relapsed/refractory metastatic triple-negative breast cancer at the symposium's general session in an event scheduled to start at 11 am. The company will also be discussing a Phase III, randomized trial of sacituzumab govitecan vs treatment of physician choice for metastatic triple-negative breast cancer tomorrow during the symposium, Immunomedics previously announced.
FCAU

Hot Stocks

12:09 EDT FCA US opens new Mopar parts distribution center in Metro Detroit - FCA US LLC officially opened a new 500,000-square-foot Mopar Parts Distribution Center in metro Detroit, marking the second new Mopar PDC to open in the U.S. this year. The Romulus, Michigan, facility employs more than 100 workers and represents an investment of $10.4M by FCA US. With an additional PDC opened earlier this year in Winchester, Virginia, FCA US has invested $22.6M in 2017 to strengthen its parts distribution network in the U.S., with 23 PDCs in North America. Combined, the two facilities represent more than 170 jobs.
IMMU

Hot Stocks

11:59 EDT Immunomedics trading resumes
WFC

Hot Stocks

11:57 EDT California Department of Insurance serve Wells Fargo with accusation - Wells Fargo was served with an accusation by the California Department of Insurance seeking to suspend or revoke its licenses for alleged improper insurance sales practices related to the company's online insurance referral program. Such practices resulted in insurance products being purchased for consumers without their knowledge, the agency said in a statement. Reference Link
IMMU

Hot Stocks

11:54 EDT Immunomedics trading halted, volatility trading pause
GHC

Hot Stocks

11:40 EDT Kaplan Professional Education to buy CFFP from Apollo Education - Kaplan Professional Education, a unit of global education provider Kaplan, a subsidiary of Graham Holdings, signed an agreement to acquire the College for Financial Planning from Apollo Education Group. Terms of the transaction were not disclosed. The acquisition is expected to close this summer, pending review by the Higher Learning Commission, CFFP's accreditor.
TMUS...

Hot Stocks

11:04 EDT T-Mobile sets share buyback plan a month after Sprint talks collapse - Shares of T-Mobile US (TMUS) are climbing in late morning trading after the "Un-carrier" announced a $1.5B stock buyback program through 2018 a month after the company and Sprint (S) ended merger talks. REPURCHASE PLAN DETAILS: T-Mobile this morning said its board authorized a plan to repurchase of up to $1.5B of its common stock, its first-ever repurchase program. In addition, Deutsche Telekom (DTEGY), T-Mobile's majority shareholder, is considering plans to purchase additional shares of T-Mobile common stock. The stock repurchases are expected to occur through December 31, 2018. "Since launching Un-carrier, T-Mobile has delivered unmatched growth and continues to take share in a rapidly changing and competitive wireless industry," T-Mobile President and Chief Executive John Legere said in a statement. "This repurchase program underscores our Board of Directors' and management team's confidence in our business and our commitment to creating value for shareholders." Legere also noted that "2018 is going to be another exciting year in wireless and we can't wait to get started." At today's UBS Global Media and Communications Conference, Chief Financial Officer Braxton Carter said T-Mobile will likely "blow through" the repurchase program and might consider "tuck-in" acquisitions over the coming year. WHAT'S NOTABLE: In November, Carter told a Morgan Stanley conference in Barcelona that the carrier would propose a "significant" share repurchase, and noted that Deutsche Telekom, which owns about 64% of the carrier, would not tender shares. T-Mobile has been in focus since merger talks with Sprint fell through due to the inability of the companies and their controlling investors to agree on a controlling stake or valuation as well as concerns over opposition from regulators. At the UBS conference, Carter, who admitted that T-Mobile is "past the Sprint deal," said that "Coming off the Sprint deal with significant shareholder rotation happening, we think that we have a tremendous value here." Chief Operating Office Mike Sievert said that T-Mobile is having a "fantastic quarter," and "the formula is really working." Looking ahead, Sievert said T-Mobile can be both "growth driven" and a "cash generator." PRICE ACTION: T-Mobile is up about 1% to $61.55 in late morning trading.
AZUL

Hot Stocks

11:01 EDT Azul announces codeshare agreement with Turkish Airlines - Azul S.A. and Turkish Airlines announce the signature of a codeshare agreement effective as of December 8. Through the codeshare partnership, Turkish will add its code on Azul domestic flights. As a result, customers will be able to purchase tickets directly from all of Turkish Airlines' sales channels to fly to Brazilian domestic destinations operated by Azul.
HSIC...

Hot Stocks

10:38 EDT Dental distributors slide as Morgan Stanley says sell on Amazon threat - Shares of Henry Schein (HSIC) and Patterson Companies (PDCO) are sliding after Morgan Stanley analyst Steve Beuchaw downgraded both stocks to Underweight, a sell-equivalent rating, as he believes Amazon's (AMZN) headway in the dental supply sector and market softness are now undeniable. SELL HENRY SCHEIN, PATTERSON: In a research note to investors this morning, Morgan Stanley's Beuchaw downgraded Henry Schein and Patterson Companies to Underweight from Equal Weight after uncovering new evidence that Amazon (AMZN) is accessing critical products from dental products maker Dentsply Sirona (XRAY) and could access dental offerings from 3M (MMM) and Danaher (DHR) over the next two years. Furthermore, the analyst pointed out that he sees signs that price/mix and volumes in the market are continuing to deteriorate both in the U.S. and Europe due to customer consolidation, alternative channels, and reimbursement. While Beuchaw thinks Henry Schein is "the best house in a tough neighborhood" and valuation still looks "generous," he sees persistent market growth moderation as likely and notes that Amazon adds pricing transparency/risk. On the other hand, the analyst believes Patterson Companies is facing more than just market headwinds and is concerned with the company's ability to stabilize the commercial organization behind new sales reps that could take another 6-9 months to ramp, during which time Henry Schein is likely to continue to pursue its customers. Beuchaw lowered his price target for Henry Schein to $65 from $73 and for Patterson Companies to $29 from $38. PRICE ACTION: In morning trading, shares of Henry Schein have dropped about 3% to $69.05, while Patterson Companies' stock has slipped about 5.5% to $34.27.
DFS

Hot Stocks

10:18 EDT Discover will no longer require signatures at checkout - Beginning in April 2018, Discover will no longer require signatures at the point of sale for credit and debit transactions on the Discover Global Network in the United States, Canada, Mexico and the Caribbean. The change is part of Discover's efforts to continually improve the payment experience by speeding up the time spent at checkout all while maintaining a high level of security for both customers and merchants. Discover has already implemented a number of digital authentication technologies such as tokenization, multi-factor authentication, and biometrics that are more secure than requiring a signature and provide a more seamless payment transaction. "As the payments industry continues to evolve and introduce new methods of transacting, we're making sure that Discover is providing customers and merchants with a smooth and more secure payments experience," said Jasma Ghai, vice president of Global Products Innovation at Discover. "With the rise in new payment security capabilities, like chip technology and tokenization, the time is right to remove this step from the checkout experience."
OSIS

Hot Stocks

10:11 EDT Block: OSI 'bottom won't fall out' if Mexico contract resumed on same terms - Carson Block of Muddy Waters is appearing on Bloomberg television to discuss his newly-disclosed short report on OSI Systems.
OSIS

Hot Stocks

10:07 EDT OSI Systems accused by Block of paying bribe to obtain Albania contract - Carson Block of Muddy Waters is appearing on Bloomberg television to discuss his newly-disclosed short report on OSI Systems, which he has accused of being corrupt.
OSIS

Hot Stocks

10:05 EDT OSI Systems drops after Muddy Waters accuses company of corruption - Muddy Waters Capital disclosed in a newly posted video short report that the research firm is shorting OSI Systems, making accusations that its key contract in Albania was obtained "through corruption." The company's most significant contract, in Mexico, is at risk of not being renewed or of being renewed at less favorable terms and U.S. and EU contracts are at risk "due to likely corruption" as well, Muddy Waters also stated in its video report. Shares of OSI Systems, which makes electronic systems and components for the homeland security, healthcare, defense and aerospace markets, are down 9% to $76.49 as Carson Block discusses the short position on Bloomberg television.
CMTL

Hot Stocks

10:01 EDT Comtech unit receives $1.9M contract modification - Comtech Telecommunications announced that during its first quarter of fiscal 2018, its Tempe, Arizona-based subsidiary, Comtech EF Data Corp., which is part of Comtech's Commercial Solutions segment, received a contract modification that funded $1.9M under an Engineering Support Services Contract Line Item. The authorized funding will be applied to support additional capabilities to the Advanced Time Division Multiple Access Interface Processor production terminals in support of the Space and Naval Warfare Systems Command.
OSIS

Hot Stocks

10:00 EDT OSI Systems plunges after Muddy Waters discloses short call on stock - Reference Link
OSIS

Hot Stocks

09:59 EDT OSI Systems drops 7% to $78.37
FRED

Hot Stocks

09:58 EDT Fred's plummets following weak results, pulling dividend - Shares of Fred's Inc (FRED) plunged in morning trading after the pharmacy operator canceled its quarterly dividend and said it was exploring alternatives for some of its noncore assets. The moves came as Fred's reported losses for the third quarter that was worse than analysts expected. DIVIDEND CANCELLED: Fred's announced this morning that it is cancelling its quarterly cash dividend in order to retain free cash flow for debt reductions, share buybacks and other corporate purchases. Fred's said future dividends will be left to the discretion of the board and will be based on the company's financial performance and available cash resources. In connection with the dividend cancellation, Fred's amended its 2012 share buyback program, which will now allow for the repurchase of up to 3.8M shares of the company's Class A voting common stock. REVIEW OF NONCORE ASSETS: In shifting its focus towards driving increased traffic, reducing costs, improving its gross margin and generating free cash flow, Fred's also said its board is considering various alternatives for its real estate and specialty pharmacy business, which the company has deemed "noncore." Fred's noted that the decision to explore alternatives for these assets is not in response to a third party proposal and the company has not decided to engage in any particular transaction. THIRD QUARTER LOSS: Fred's also announced a wider than expected loss for the third quarter, with a loss per share including charges of ($1.38), well below analysts' (13c) estimate. Revenue for the quarter of $493.6M also fell below the $499.75M consensus and comparable store sales, which included a negative 36 basis point impact as a result of the sale of low productive discontinued inventory versus last year, dropped 0.8% versus a 3.8% decline last year. CEO Michael Bloom commented that Fred's has seen a "complete turnaround in our tobacco business, significantly enhanced cosmetics and successfully rolled out beer to approximately 150 stores and wine to approximately 50 stores. We have also kicked off a reduced price endcap test, which is showing promising results, and we intend to roll it out to all stores." However, Bloom cautioned that the company is "not yet at the point of presenting positive quarterly comp sales and traffic improvement; however, we are improving month-by-month as our initiatives are yielding results. We recognize that there is more work to be done, but we are encouraged by the traction our initiatives are gaining and look forward to capitalizing on that momentum in the coming quarters." WHAT'S NOTABLE: In September, Fred's extended a shareholder rights plan to September 18, 2020 and lowered the trigger to 4.9% ownership from 10%. PRICE ACTION: Fred's is down 22.4% to $3.95 per share in morning trading.
AEO

Hot Stocks

09:54 EDT American Eagle sees about 2%-3% growth in SSS in 2018
FAST

Hot Stocks

09:50 EDT Fastenal reports November net sales up 15.4% to $365.5M - Fastenal reports net sales grew 15.4% in November compared to last year to $365.5M. Daily sales of $17.4M were up 15.4%.
X

Hot Stocks

09:49 EDT U.S. Steel issues statement on Department of Commerce circumvention ruling - United States Steel issued the following statement in response to the Department of Commerce's preliminary ruling on circumvention petitions filed by American steel producers in September 2016. The preliminary found that imports of Chinese steel that is finished in Vietnam are covered by U.S. antidumping and countervailing duty orders on imports from China. As a result of DOC's preliminary decision, U.S. importers of cold-rolled and galvanized steel from Vietnam must make cash deposits equal to the applicable duties. DOC's final decision could be as early as February 2018. The company's statement follows: "The Commerce Department's finding of circumvention represents a critical step to shutting down one of the many paths used to flood the U.S. with dumped and subsidized steel. This decision presents an encouraging sign for the steel industry and should put other countries and companies on notice that their cheating will no longer be tolerated. We urge Secretary Ross and President Trump to continue to aggressively crack down on unfairly traded steel imports, including immediate and broad action in the Section 232 investigation on steel imports and national security."
DUK

Hot Stocks

09:48 EDT Duke Energy acquires full ownership of REC Solar - Duke Energy announced that it has acquired full ownership of California-based REC Solar, a provider of renewable energy solutions for commercial customers throughout the U.S. Duke Energy first acquired a majority interest in REC Solar in February of 2015. RREC Solar will continue to be a part of Duke Energy Renewables, Duke Energy's commercial renewables organization. Duke Energy purchased the remaining shares of REC Solar in a cash transaction. Details were not disclosed. REC Solar will be managed as an independent business unit of Duke Energy Renewables.
AEO

Hot Stocks

09:47 EDT American Eagle says expects cash flow, EPS to benefit from tax reform - Says plans for returning capital to shareholders hasn't changed, although would like to be more consistent with share buybacks.
INSY

Hot Stocks

09:39 EDT Insys Therapeutics says FDA accepts NDA for buprenorphine sublingual spray - INSYS Therapeutics announced that its New Drug Application for a novel formulation of buprenorphine as a sublingual spray for the management of moderate-to-severe acute pain has been accepted for filing by the U.S. FDA. Under the Prescription Drug User Fee Act, the FDA has set a target date of July 28, 2018 to complete its review of this NDA, which was based primarily on a pivotal trial that met its primary efficacy endpoint and several pharmacokinetics studies. To expand the duration of exposure for this investigation new drug candidate, INSYS also recently completed a seven-day safety and tolerability study with 100 patients. Data from this study will be submitted to the FDA in the first quarter of 2018, augmenting the NDA package, and may impact the PDUFA date. INSYS anticipates that the potential benefits of buprenorphine include a ceiling effect for respiratory depression and, compared to other opioids frequently used in this indication, less abuse potential, less cognitive impairment and less constipation.
VKTX MDGL

Hot Stocks

09:30 EDT Viking Therapeutics jumps following Madrigal trial success - Shares of Viking Therapeutics (VKTX) are jumping after Madrigal Pharmaceuticals (MGDL) announced that its Phase 2 clinical trial in patients with biopsy-proven non-alcoholic steatohepatitis demonstrated statistically significant results for the primary endpoint. Madrigal's MGL-3196 is a first-in-class, oral, once-daily, liver-directed, thyroid hormone receptor. Viking has initiated Phase 2 clinical development of its VK 2809, an agonist of the thyroid beta, in hypercholesterolemia and fatty liver disease. The company last night announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. Bloomberg, citing a person familiar with the process, reported this morning that Viking's offering is expected to price post today's market close.. Viking shares are up 31%, or 84c, to $3.58 in premarket trading following Madrigal's trial success. Madrigal shares are up 51%, or $23.70, to $70.00.
AEO

Hot Stocks

09:28 EDT American Eagle says feels inventory levels 'very clean' - Says in "very good shape" from aging perspective.
WMT

Hot Stocks

09:25 EDT Wal-Mart to change name to Walmart Inc, effective February 1 - Reflecting its growing status as an omni-channel retailer Walmart announced plans to change the company's legal name from Wal-Mart Stores, Inc. to Walmart Inc. effective Feb. 1, 2018. The name change chiefly demonstrates the company's growing emphasis on serving customers seamlessly however they want to shop: in stores, online, on their mobile device, or through pickup and delivery. Walmart will continue to trade on the NYSE as WMT and the company name should be referenced as Walmart.
WMT

Hot Stocks

09:24 EDT Wal-Mart to change name to Walmart Inc, effective February 1 - Reflecting its growing status as an omni-channel retailer Walmartannounced plans to change the company's legal name from Wal-Mart Stores, Inc. to Walmart Inc. effective Feb. 1, 2018. The name change chiefly demonstrates the company's growing emphasis on serving customers seamlessly however they want to shop: in stores, online, on their mobile device, or through pickup and delivery. Walmart will continue to trade on the NYSE as WMT and the company name should be referenced as Walmart.
AEO

Hot Stocks

09:23 EDT American Eagle says expects gross margin, Opex improvements to continue in 2018
AMZN AAPL

Hot Stocks

09:23 EDT Amazon: Prime Video app now available on Apple TV in over 100 countries - Amazon (AMZN) announced the Prime Video app is available on Apple (AAPL) TV 4K and previous generations of Apple TV in over 100 countries. Amazon said: "Prime Video members now have even more ways to stream award-winning and critically-acclaimed titles including Amazon Original Movies, Prime Originals and Hollywood blockbusters and TV series and over 140 Channel subscriptions in the US and 95 in the UK, Germany and Austria. Starting tomorrow, customers can enjoy Thursday Night Football live on Apple TV 4K and Apple TV. Amazon's library of 4K High Dynamic Range titles are available on Apple TV 4K. Finding content on Prime Video is remarkably easy for Apple TV viewers with the Apple TV App, Siri Remote and universal search in select countries."
GSM

Hot Stocks

09:22 EDT Ferroglobe announces purchase of company shares by CEO, CFO, Executive Chairman - Ferroglobe announced that members of its senior management, including its Executive Chairman, Javier Lopez Madrid, CEO, Pedro Larrea Paguaga, and its CFO, Joe Ragan, made open-market purchases of shares of Ferroglobe on December 5, 2017, December 1, 2017 and November 30, 2017, respectively. Mr. Lopez Madrid purchased 10,000 shares at a price of $15.73 per share, Mr. Larrea purchased 8,000 shares at a price of $16.45 per share and Mr. Ragan purchased 5,300 shares at a price of $16.35 per share.
AEO

Hot Stocks

09:21 EDT American Eagle sees Q4 SSS growth in mid single digits
VTGN

Hot Stocks

09:20 EDT VistaGen granted U.S. patent regarding methods of production for AV-101 - VistaGen Therapeutics announced the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,834,801 related to certain methods of production for AV-101, VistaGen's lead CNS product candidate.
AEO

Hot Stocks

09:20 EDT American Eagle says sees Q4 inventory up about 10% - Says looking to refine store base, currently testing new store designs.
JCI

Hot Stocks

09:17 EDT Johnson Controls raises quarterly dividend to 26c from 25c per share - Payable on Jan.12, 2018, to shareholders of record at the close of business on Dec.18, 2017.
VRA...

Hot Stocks

09:16 EDT On The Fly: Pre-market Movers - UP AFTER EARNINGS: Vera Bradley (VRA), up 9.1%... American Eagle Outfitters (AEO), up 6.8%... Brown-Forman (BF.A, BF. B), up 2.2%. ALSO HIGHER: Davita (DVA), up 10.9% following an announcement that it will be acquired by Optum, part of UnitedHealth Group (UNH). UnitedHealth Group is up fractionally... Arrowhead Pharmaceuticals (ARWR), up 5.4% after presenting new data showing sustained host response in HBV patients... Carnival (CCL), up 1.1% after being upgraded to Equal Weight from Underweight at Morgan Stanley. DOWN AFTER EARNINGS: Fred's (FRED), down 21.4%... Bob Evans (BOBE), down 1%. ALSO LOWER: Tronox (TROX), down 20.3% after the Federal Trade Commission issued an administrative complaint challenging Tronox's acquisition of Cristal... Tabula Rasa HealthCare (TRHC), down 2.3% after its 3M share Secondary priced at $27.50.
AEO

Hot Stocks

09:12 EDT American Eagle says digital sales 'extremely strong' in Q3 - Says to date, holiday season has been "terrific."
AEO

Hot Stocks

09:10 EDT American Eagle says Cyber Monday was best online sales day ever - Says "never more ready" for holiday season. Comments from Q3 earnings conference call.
ICON

Hot Stocks

09:08 EDT Iconix Brand sees Q3 non-cash charge of about $15M - As previously disclosed, the company accelerated the timing of its annual impairment testing of goodwill and intangible assets that is customarily performed in connection with the preparation of year-end financial statements and is in the process of completing such testing in connection with the preparation of its financial statements for the quarter ended September 30, 2017. The Company has not yet finalized its impairment analysis, however, as a result of such testing which will be completed prior to the filing of the Company's Form 10-Q for the period ended September 30, 2017, the Company expects to recognize a non-cash intangible asset impairment charge of approximately $500M-$750M primarily related to the women's segment. The company also expects to have a non-cash tax charge of approximately $15M related to the write off of certain deferred tax assets.
OMED

Hot Stocks

09:07 EDT Perceptive Advisors reports 6.5% passive stake in OncoMed - Perceptive Advisors disclosed a 6.5% stake in OncoMed Pharmaceuticals, which represents over 2.47M shares. The filing does not allow for activism.
CYTR

Hot Stocks

09:06 EDT CytRx files key patent applications for ultra-high potency LADR drug candidates - CytRx announced that it has filed provisional patent applications covering two series of drug candidates from its LADR Technology Platform. The newly filed applications cover compounds, pharmaceutical compositions and methods of use thereof. When granted, these new patents will expand CytRx's intellectual property estate and the company will own worldwide rights for each.
EXPE

Hot Stocks

09:04 EDT Expedia, G6 Hospitality form strategic technology and marketing partnership - Expedia officially announced a new Expedia Powered Technology partnership with G6 Hospitality, parent company of the lodging brands Motel 6 and Studio 6, that will provide the brands broad access to Expedia's technology, marketing and data insight solutions to help drive knowledge, efficiencies and support its continued growth.
WSM

Hot Stocks

09:04 EDT Williams-Sonoma expands partnership with Leesa Sleep - Pottery Barn, a member of the Williams-Sonoma portfolio of brands, announces its partnership with Leesa Sleep, a company engaged in the emerging direct-to-consumer online mattress industry. Starting today, Pottery Barn customers can purchase Leesa's American-made and expertly designed mattresses online at PotteryBarn.com/Leesa, marking Leesa's growing partnership with Williams-Sonoma, Inc. after a successful launch with West Elm in September. As with West Elm, Pottery Barn shares Leesa's commitment to the community and, as part of the expansion, the brands will join forces to give Leesa mattresses and Pottery Barn sheet sets to San Francisco's Episcopal Community Services' housing program at The Hillsdale, and will continue to donate one mattress for every 10 sold as a part of Leesa's "One-Ten" social impact program.
MXIM

Hot Stocks

09:03 EDT Maxim Integrated signs catalog distribution agreement with CoreStaff Co. - Maxim Integrated Products announced that it has signed a catalog distribution agreement with CoreStaff Co., Ltd., one of Japan's largest online shopping sites for semiconductors, electronic parts, and module products. The agreement is effective as of November 3, 2017.
JUNO LLY

Hot Stocks

09:02 EDT Juno Therapeutics signs licensing deals with Lilly, OncoTracker - Juno Therapeutics (JUNO) announced three license agreements to advance its program in multiple myeloma using gamma secretase inhibitors in combination with BCMA-directed CAR T cells. Through its agreement with Eli Lilly and Company (LLY), Juno will acquire a license to the GSI known as LY3039478, a product candidate that has been studied in 411 patients and healthy volunteers. Through its agreements with OncoTracker and Fred Hutchinson Cancer Research Center, Juno will gain exclusive rights to intellectual property within the field of combinations of GSIs and BCMA-directed engineered T cells. No other terms from these three transactions were disclosed.
ICON

Hot Stocks

09:02 EDT Iconix Brand sees FY17 results 'be within previously issued guidance' - The company believes that, excluding the impact of the intangible asset impairment charge discussed above, full year 2017 results will be within previously issued guidance.
HRS

Hot Stocks

09:01 EDT Harris to provide tactical communications for Army's SFAB - Harris Corporation has been selected to outfit U.S. Army Security Force Assistance Brigades, or SFABs, with reliable and combat-proven communication systems. Harris will provide a full battlefield solution including its Falcon III AN/PRC-152A Wideband Networking Handheld Radios and AN/PRC-117G Multiband Networking Manpack Radios, as well as its AN/PRC-160 High Frequency Manpack Radios. The radios will be equipped with the Soldier Radio Waveform and the Adaptive Networking Wideband Waveform, providing robust battlespace communications.
HRS

Hot Stocks

09:01 EDT Harris to provide tactical communications for Army's SFAB - vHarris Corporation has been selected to outfit U.S. Army Security Force Assistance Brigades, or SFABs, with reliable and combat-proven communication systems. Harris will provide a full battlefield solution including its Falcon III AN/PRC-152A Wideband Networking Handheld Radios and AN/PRC-117G Multiband Networking Manpack Radios, as well as its AN/PRC-160 High Frequency Manpack Radios. The radios will be equipped with the Soldier Radio Waveform and the Adaptive Networking Wideband Waveform, providing robust battlespace communications.
DE...

Hot Stocks

08:39 EDT Deere elects Charles Holliday, Jr. to board, effective January 1, 2018 - Deere & Company (DE) announced the election of Charles Holliday, Jr. to the company's Board of Directors, effective January 1, 2018. Holliday previously served on the Deere & Company Board from 2007 to 2016. Holliday has been chairman of Royal Dutch Shell (RDS.A) since May 2015 and previously served as chairman and CEO of DuPont (DWDP), chairman of Bank of America (BAC), and chairman of the National Academy of Engineering.
VRA

Hot Stocks

08:37 EDT Vera Bradley up 4.8% after reporting Q3 results
VRA

Hot Stocks

08:37 EDT Vera Bradley CEO says Vision 20/20 plan implemented more quickly than expected - Robert Wallstrom, CEO, noted, "Our ability to implement certain expense reductions in conjunction with the initial implementation of our Vision 20/20 plan more quickly than originally expected, along with diligent expense management, drove third quarter EPS meaningfully ahead of our guidance." Wallstrom further noted, "As we discussed last quarter, we have launched Vision 20/20, an aggressive plan to turn around our business over the next three years. Vision 20/20 will restore brand and company health by moving to a less clearance-driven business model combined with a meaningful reduction in our SG&A expenses. "In addition to resetting customers' pricing expectations and restoring our full-price business by significantly reducing the amount of clearance product available on verabradley.com and in our full-line stores, we are also focusing on streamlining our current product offerings by eliminating unproductive or incongruent categories and SKUs from our assortment. In addition, we are building more discipline into our overall assortment architecture by developing strong guardrails around introducing new categories, prices, and patterns." The majority of the product and pricing initiatives will be implemented beginning in fiscal 2019; management expects annualized revenues will be negatively impacted by these initiatives by $30 million to $50 million in fiscal 2019 from fiscal 2018 levels. Management expects to reduce annual net SG&A spending by up to $30 million from the baseline fiscal 2017 level of $236 million by right-sizing the organization to better align with the reduced size of the business. Certain cost reductions have already begun and are reflected in the company's third quarter results and in fourth quarter and fiscal 2018 SG&A guidance. Management expects that $20 million to $25 million of the annualized SG&A reductions will be made by the end of fiscal 2019. The company will provide more complete financial guidance for fiscal 2019 in conjunction with its fourth quarter and fiscal year-end earnings release on March 14, 2018. "Vision 20/20 is setting the right course for the future of Vera Bradley by restoring our brand health and improving operating performance," Wallstrom concluded. "Of course, we also remain keenly focused on our customer and driving brand desirability through product and marketing innovation, newness, and creativity."
RNR

Hot Stocks

08:31 EDT RenaissanceRe announces $90M negative impact from October wildfires - RenaissanceRe Holdings Ltd. announced it currently estimates that losses from the October 2017 California Wildfires will have a net negative impact of $90M on its fourth quarter 2017 results of operations. The October 2017 California Wildfires caused widespread damage to both personal and commercial property in and around the impacted regions.
NERV

Hot Stocks

08:31 EDT Minerva enrolls first patient in Phase 2b trial of seltorexant - Minerva Neurosciences announced the enrollment of the first patient in a Phase 2b clinical trial of seltorexant in patients with insomnia disorder. A total of approximately 360 patients 18 to 85 years of age will be randomized in this study at clinical sites in the United States, European Union and Japan. The duration of participation in this study for an individual subject will be up to 61 days, including screening and follow-up.
ALOT AMOT

Hot Stocks

08:30 EDT AstroNova names Allied Motion CEO Richard Warzala to board - AstroNova (ALOT) announced that Richard "Dick" Warzala, Chairman and CEO of Allied Motion Technologies (AMOT), has been appointed to the AstroNova Board of Directors, effective immediately.
VRA

Hot Stocks

08:30 EDT Vera Bradley trading resumes
HRB

Hot Stocks

08:18 EDT H&R Block down 1% after reporting Q2 results
VAR

Hot Stocks

08:16 EDT Varian Medical: Halcyon treatment system granted ANVISA registration in Brazil - Varian announced the Halcyon system has received ANVISA registration in Brazil. This registration allows Varian to market this new system in Brazil. Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy, and is well suited to treat a majority of cancer patients, offering advanced treatments for prostate, breast, head & neck, and many other forms of cancer.
RLJ

Hot Stocks

08:16 EDT RLJ Lodging Trust expands relationship with Interstate Hotels and Resorts - RLJ Lodging Trust announced that it has expanded its relationship with Interstate Hotels and Resorts in connection with White Lodging's sale of management contracts to Interstate. The transaction is expected to close on or about January 31, 2018. The terms of the original White Lodging contracts will remain in effect. "This transaction will result in Interstate Hotels becoming our largest management company," commented Ross H. Bierkan, President and CEO. "We value our long-standing relationship with White Lodging and thank them for their management of these assets. Interstate is an excellent operator and already manages 11 of our hotels. We are excited to expand our relationship with Interstate and look forward to the fresh perspective they will bring to these assets." Once the transaction is completed, the company will have 73 hotel management contracts with Interstate, including 62 hotel contracts acquired from White Lodging, which represent less than 20% of the company's hotel EBITDA. White Lodging will continue to manage 9 of the company's hotels.
CLRB

Hot Stocks

08:12 EDT Cellectar Biosciences announces expansion of R/R MM cohort in CLR 131 trial - Cellectar Biosciences announces that the company will increase the targeted patient enrollment in the relapsed/refractory, or R/R, multiple myeloma, or MM, cohort of its currently enrolling Phase 2 clinical trial of CLR 131. Data from the MM cohort of the study demonstrated that the treatment exceeded pre-specified criteria for clinically meaningful benefit. As a result, the cohort will be expanded up to as many as 40 patients.
TAYD

Hot Stocks

08:10 EDT Taylor Devices receives $3.2M contract for seismic dampers - Taylor Devices announced receipt of a $3.2M contract for the firm's seismic dampers being used in a seismic protection upgrade at the St. Bernardine Medical Center, San Bernardino, CA. A total of 108 large dampers, each rated at up to 0.75M pounds output, will be used to absorb earthquake energy in the hospital building, originally constructed in 1972. The dampers will be used to absorb the earthquake shaking energy, before it can damage the original structure, greatly reducing potential risk to the building, occupants, and equipment.
HCI

Hot Stocks

08:09 EDT HCI Group announces $20M stock repurchase program - The board of HCI Group has authorized a program to repurchase up to $20M of the company's common shares during 2018.
HOLX

Hot Stocks

08:09 EDT Hologic receives FDA 510(k) clearance for Panther Fusion AdV/hMPV/RV assay - Hologic announced that it has received 510(k) clearance from the United States FDA for its Panther Fusion AdV/hMPV/RV assay, a multiplexed assay that runs on the new Panther Fusion system. The new assay detects Adenovirus, human Metapneumovirus, and Rhinovirus. It is the third diagnostic assay available on the Panther Fusion system, complementing the Panther Fusion Flu A/B/RSV assay and the Panther Fusion Paraflu assay, which both received clearance in October 2017
DECK

Hot Stocks

08:08 EDT Deckers Brands sends letter highlighting support from Glass Lewis - Deckers Brands said that its Board of Directors is sending a letter to stockholders highlighting support from leading proxy advisory firm Glass Lewis, as well as Deckers' sell-side analysts. Deckers' Board of Directors unanimously recommends that stockholders vote "FOR" ALL of Deckers' nominees using the WHITE proxy card. "As you may know, in a last-minute and desperate attempt to gain board representation, Marcato Capital Management has abandoned its previously announced strategy for a change in the composition of a majority of the Deckers Board and is now seeking any representation on the Deckers Board that it can get. Don't be fooled: Marcato is continuing to put the value of your investment in Deckers at risk by advocating for a series of value-destructive proposals and the election of three nominees who lack the relevant skills and experience to continue our successful transformation. Don't let Marcato interrupt Deckers' transformation. We have the right Board and the right plan already underway to position Deckers for the future and drive enhanced stockholder value. Leading proxy advisory firm Glass Lewis recommends that Deckers stockholders vote on the WHITE proxy card for all of Deckers' highly qualified director nominees. This reflects Glass Lewis' belief that the right stewards for Deckers are the existing highly qualified and experienced nominees put forth by Deckers, who have already demonstrated that they have the right strategy to grow stockholder value."
ITGR

Hot Stocks

08:08 EDT Integer wins long-term supply agreement with Neuros Medical - Integer announced that its subsidiary, Centro de Construccion de Cardioestimuladores del Uruguay S.A., has signed a ten-year supply agreement with Neuros Medical. Under the new agreement, CCC will be the sole supplier of key "Products" for Neuros' Altius System. The Products include the implantable generator and related external devices.
DECK

Hot Stocks

08:08 EDT Deckers Brands sends letter highlighting support from GLass Lewis - Deckers Brands said that its Board of Directors is sending a letter to stockholders highlighting support from leading proxy advisory firm Glass Lewis, as well as Deckers' sell-side analysts. Deckers' Board of Directors unanimously recommends that stockholders vote "FOR" ALL of Deckers' nominees using the WHITE proxy card. "As you may know, in a last-minute and desperate attempt to gain board representation, Marcato Capital Management has abandoned its previously announced strategy for a change in the composition of a majority of the Deckers Board and is now seeking any representation on the Deckers Board that it can get. Don't be fooled: Marcato is continuing to put the value of your investment in Deckers at risk by advocating for a series of value-destructive proposals and the election of three nominees who lack the relevant skills and experience to continue our successful transformation. Don't let Marcato interrupt Deckers' transformation. We have the right Board and the right plan already underway to position Deckers for the future and drive enhanced stockholder value. Leading proxy advisory firm Glass Lewis recommends that Deckers stockholders vote on the WHITE proxy card for all of Deckers' highly qualified director nominees. This reflects Glass Lewis' belief that the right stewards for Deckers are the existing highly qualified and experienced nominees put forth by Deckers, who have already demonstrated that they have the right strategy to grow stockholder value."
CTXR

Hot Stocks

08:07 EDT Citius Pharmaceuticals: Mino-Lok Phase 3 trial supplies shipped to sites - Citius Pharmaceuticals has announced that clinical trial supplies of Mino-Lok have been sent to the University of Chicago Medical Center, and the Henry Ford Health System in Detroit, the first 2 clinical trial sites for the Mino-Lok phase 3 pivotal trial. When fully recruited, it is planned that there will be 50 participating sites, all located in the U.S. Mino-Lok is under investigation and not approved for commercial use.
TMUS DTEGY

Hot Stocks

08:06 EDT T-Mobile announces $1.5B stock repurchase program - T-Mobile US (TMUS) announced that its Board of Directors authorized a stock repurchase program for up to $1.5B of T-Mobile's common stock through December 31, 2018. "Since launching Un-carrier, T-Mobile has delivered unmatched growth and continues to take share in a rapidly changing and competitive wireless industry. This repurchase program underscores our Board of Directors' and management team's confidence in our business and our commitment to creating value for shareholders," said John Legere President and CEO of T-Mobile. "Our strong balance sheet and cash flow generation give us the ability to return capital while continuing to make significant investments in our network and operations. 2018 is going to be another exciting year in wireless and we can't wait to get started." T-Mobile also commented, "We also understand that Deutsche Telekom AG (DTEGY), our majority stockholder, or its affiliates, is considering plans to purchase additional shares of our common stock. Such purchases would likely take place through December 31, 2018, all in accordance with the rules of the Securities and Exchange Commission and other applicable legal requirements."
UA...

Hot Stocks

08:05 EDT Harman, Under Armour announce launch of UA Sport Wireless Flex headphones - HARMAN International, a wholly-owned subsidiary of Samsung Electronics (SSNLF), and Under Armour (UA, UAA), announced the launch of UA Sport Wireless Flex headphones. "These wireless neckband headphones epitomize intuitive, sleek design, remarkable sound quality and impressive versatility to provide athletes with a secure fit when at the gym or on-the-go," the companies said.
GHDX JNJ

Hot Stocks

08:04 EDT Genomic Health announces research collaboration with Janssen Pharmaceuticals - Genomic Health (GHDX) announced a multi-year research collaboration agreement with Janssen Pharmaceuticals (JNJ) to evaluate the Oncotype DX Genomic Prostate Score test for their prostate cancer drug pipeline. As part of the agreement, Genomic Health will test samples from Janssen studies to examine the association of GPS results with clinical outcomes.
CRL

Hot Stocks

08:04 EDT Charles River adds ERS license to CRISPR/Cas9 service offering - Charles River Laboratories International announced the expansion of its CRISPR/Cas9 service offering with the addition of a license from ERS Genomics Limited. The license, coupled with the existing license through the Broad Institute of MIT and Harvard, allows Charles River to offer custom in vivo and in vitro genome editing.
CVNA

Hot Stocks

08:03 EDT Carvana launches second Arizona market with expansion into Tucson - Carvana announced its expansion into Tucson, the company's second market in Arizona. Area residents can shop more than 8,000 vehicles, finance, purchase and even trade in an old car in as little as 10 minutes from the comfort of home or on the go from their mobile device - all with free, as-soon-as-next-day vehicle delivery.
CVS

Hot Stocks

08:03 EDT CVS Pharmacy launches free, same-day prescription delivery in Manhattan - CVS Pharmacy introduced free, same-day delivery for prescriptions and certain over-the-counter items in Manhattan this week. The new free delivery service makes it easier for customers to save time and stay healthy. Free, same-day delivery in Manhattan is one of CVS Pharmacy's national network of delivery solutions. Same-day delivery in additional cities and next-day, nationwide delivery will be launching in early 2018. This week, CVS Pharmacy began offering delivery service from all locations in Manhattan. Prescriptions and the option of adding a selection of over-the-counter products can be delivered directly from CVS Pharmacy in secure tamper-proof packaging right to the customer's door to assure complete privacy. Over-the-counter items that can be added to a prescription delivery include popular items to treat cough, cold and flu symptoms, along with other common conditions. Orders made by 11 a.m. are delivered by 4 p.m., or by 4 p.m. for 8 p.m. delivery.
AEO

Hot Stocks

08:02 EDT American Eagle continues to see FY17 CapEx $160M-$170M
AHL

Hot Stocks

08:01 EDT Aspen Insurance names David Schick as Group COO - Aspen Insurance Holdings announced that David Schick has been appointed Group COO. David joins Aspen from Maybank where he was Executive Vice President, Group Strategy and Transformation and Director of Strategic Operational Excellence. David replaces Richard Thornton who is leaving the business after almost four years at Aspen.
VRA

Hot Stocks

07:55 EDT Vera Bradley trading halted, news pending
COTY...

Hot Stocks

07:53 EDT Coty wins EU Court ruling prohibiting online selling by Parfumerie Akzente - The Court of Justice of the EU ruled that Coty's (COTY) German subsidiary, Coty Germany, could prohibit Parfumerie Akzente from selling its luxury products online through Amazon (AMZN) or Ebay (EBAY). Reference Link
PFE

Hot Stocks

07:32 EDT Pfizer: Updated data from Phase 3 trial confirms improvement in PFS - Pfizer announced updated progression-free survival results from the Phase 3 PALOMA-2 trial reinforcing the clinical benefit of IBRANCE combined with letrozole. The data, which will be presented at the 2017 San Antonio Breast Cancer Symposium on December 8, demonstrate that the combination of IBRANCE plus letrozole reduced the risk of disease progression by 44 percent and improved median PFS by more than one year compared to letrozole plus placebo when used as the initial treatment for postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer. This updated, post-hoc analysis included a median follow-up of more than three years, which is the longest to date of any Phase 3 study of a CDK 4/6 inhibitor. The updated data are consistent with results from the primary analysis for PALOMA-2, which showed a median PFS for women treated with IBRANCE plus letrozole of 24.8 months compared with 14.5 months for women treated with letrozole plus placebo. Consistent with findings from the primary analysis, the updated data demonstrate that clinical benefit was observed across all patient subgroups receiving the combination of IBRANCE and letrozole. Overall survival data were not yet mature at the time of this updated PFS analysis.
STKL

Hot Stocks

07:31 EDT SunOpta announces investment in roasted snacks capabilities - SunOpta said it is making a significant investment in its roasted snacks operations at its facility in Crookston, MN. In conjunction with the investment, customers and capabilities from its Wahpeton, ND roasting facility will be consolidated into the Crookston location, and operations at the Wahpeton location are anticipated to cease during the second fiscal quarter of 2018. These investments further the company's ongoing commitment to produce food products of the highest quality and safety for its customers and are expected to provide significant operational efficiencies as part of the company's ongoing portfolio optimization strategy and Value Creation Plan. The company expects to incur expenses relating to the Wahpeton facility closure of approximately $2M-$2.5M related to asset impairment charges and severance costs of which less than $1M is expected to be cash. These charges are expected to be recognized during the fourth quarter of fiscal 2017.
DAL

Hot Stocks

07:18 EDT Delta Air Lines, WestJet agree to form joint venture - Delta Air Lines and WestJet have agreed to deepen their existing partnership by entering into a comprehensive transborder joint venture that will increase travel choices between the U.S. and Canada. The airlines have entered into a preliminary memorandum of understanding regarding their intention to deepen their existing partnership to form an commercial joint venture arrangement, which will offer customers access to a transborder route network, airline products, enhanced frequent flyer benefits, shared airport facilities and amenities, and a more seamless travel experience.
ALPN

Hot Stocks

07:13 EDT Alpine Immune reports results of preclinical study of immuno-oncology molecules - Alpine Immune Sciences announced results of a preclinical study of novel immuno-oncology molecules derived from the company's variant immunoglobulin domain platform. Alpine scientists fused these novel molecules with trastuzumab with the goal of activating T cells against HER2-positive tumors in the tumor microenvironment. Results showed these trastuzumab-ICOSL "V-mAbs" promoted T cell proliferation and cytokine secretion and enhanced killing of tumor cells. "These preclinical data clearly indicate that the V-mAb format for our unique vIgD platform can yield novel HER2-targeted, T cell-activating immunotherapies. With these findings, we are encouraged that the V-mAb format more broadly will be able to enable target- or tumor-specific immune modulation by our vIgDs for this and many other therapeutic applications," said Stanford Peng, Executive VP of Research and Development and Chief Medical Officer of Alpine.
FMI

Hot Stocks

07:13 EDT Foundation Medicine data supports use of assay for personalized medicine - Foundation Medicine announced that new data generated with FoundationOne Heme, its comprehensive genomic profiling assay for hematologic malignancies and sarcomas, will be presented at the American Society of Hematology Annual Meeting. Data from a broad range of blood cancers, including acute myeloid leukemia, myeloproliferative neoplasms, and non-Hodgkin lymphoma, including primary central nervous system lymphoma, demonstrate the value of integrating FoundationOneHeme into clinical care. The data presented is expected to demonstrate the potential for CGP to improve disease classification, to offer personalized prognostic information and to support therapeutic treatment decision making by informing treating physicians about the use of novel treatment options, including cancer immunotherapies. New results also support the role of FoundationOneHeme to guide therapy selection and predict response to treatment. In an oral study to be presented, FoundationOneHeme detected NTRK fusions in a wide variety of hematologic malignancies, and clinical response to a TRK inhibitor was subsequently observed in a patient with refractory AML and an ETV6-NTRK2 fusion. In another study to be presented, CGP offered insights that may facilitate risk-adapted clinical management decisions in patients with intermediate-and favorable-risk AML, potentially informing optimal use of autologous stem cell transplantation over conventional consolidation chemotherapy. For example, the study showed the presence of PTPN11 mutations to predict long term clinical outcomes following an auto-SCT. Other results to be presented at ASH demonstrate the ability of FoundationOneHeme to detect both known and novel BCL6 rearrangements in NHL, including cases that previously tested negative with standard-of-care single marker testing. BCL6 rearrangements have known diagnostic and prognostic utility in specific subtypes of NHL.
EPD

Hot Stocks

07:11 EDT Enterprise Products to convert NGL pipeline to crude oil service - Enterprise Products Partners announced plans to convert one of its natural gas liquids pipelines that transports NGLs from the Permian Basin to the Texas Gulf Coast to crude oil service. The conversion is expected to be completed in the first half of 2020. This pipeline conversion would provide the partnership with total crude oil pipeline capacity of over 650,000 barrels per day from the Permian Basin to Enterprise's crude oil hub in the Houston area. Enterprise has three existing NGL pipelines that stretch from the Permian Basin to the Texas Gulf Coast: the Seminole Blue, Seminole Red and Chaparral. The Shin Oak NGL pipeline, which is currently under construction, will be the partnership's fourth NGL pipeline from the Permian Basin to the Texas Gulf Coast. The Shin Oak pipeline is expected to be in service in the second quarter of 2019. The completion of the Shin Oak pipeline provides Enterprise the flexibility to divert NGL volumes from at least one of its existing NGL pipelines onto Shin Oak and repurpose the vacated NGL pipeline to crude oil service. Enterprise is currently evaluating which NGL pipeline(s) to repurpose.
ARWR

Hot Stocks

07:10 EDT Arrowhead presents new data showing sustained host response in HBV patients - Arrowhead Pharmaceuticals presented new data from the company's Phase 2 clinical study in patients that received multiple doses of ARC-520, the company's prior generation RNAi-based clinical candidate against chronic hepatitis B infection. A maximum reduction from baseline in HBV surface antigen of 5.0 log10 was achieved seven months following the administration of the last dose of ARC-520, with the lowest absolute level observed being just above the lower limit of HBsAg quantitation. These data, presented at the 22nd biennial HEP DART meeting held in Kona, Hawaii, from Dec. 3-7, indicate that multiple doses of an RNAi-based therapy may lead to a host response that is sustained after therapy is concluded. In an oral presentation titled, "Looking Back to Move Forward - Designing Next Gen RNAi for HBV," Dr. Given showed key evidence for the first time that 2 of 3 HBV e-antigen positive patients and 2 of 5 HBeAg negative patients treated with an RNAi-based therapy achieved a sustained host response off therapy. This was characterized by continued reduction of multiple HBV viral markers, including HBsAg, and coinciding with an increase in circulation of liver enzyme alanine aminotransferase, indicative of host response. The new data from Heparc-2001, the company's Phase 2 open-label extension study of ARC-520 in combination with entecavir in 8 patients, follows patients over 7 months after the last ARC-520 dose was administered, which is the last time point currently available.
ERN

Hot Stocks

07:09 EDT Erin Energy announces spud of Oyo-NW well - Erin Energy announced it has commenced drilling of the Oyo North West well. Oyo-NW is a high-impact exploration well being drilled with the Pacific Bora, a sixth-generation drilling rig, on the company's offshore Nigeria block 120. The well is expected to take approximately 60 days to drill and log. Erin Energy also stated that upon a successful discovery, given the close proximity to its current floating production and offloading facilities located on the producing Oyo Field, the company would plan to eventually complete the well as a producer with production tie-back to the Oyo Field facilities.
CCNI

Hot Stocks

07:08 EDT Command Center, Inc announces 1-for-12 reverse stock split - Command Center is announcing a 1-for-12 reverse split of its common and preferred stock, effective as of the close of business tomorrow, December 7, 2017.
GPRK

Hot Stocks

07:08 EDT GeoPark announces further extension of Tigana oil field in Colombia - GeoPark Limited announced the drilling and testing of the Tigana Norte 4 appraisal well in the Tigana oil field in Llanos 34 block in Colombia. GeoPark drilled and completed the Tigana Norte 4 well to a total depth of 11,730 feet. Oil shows during drilling and petrophysical analysis indicated the potential for hydrocarbons in both Guadalupe and Mirador formations. A production test conducted with an electric submersible pump in the Guadalupe formation resulted in a production rate of approximately 1,900 bopd of 14.1 degrees API, with approximately 1.8% water cut, through a choke of 34/64 inches and wellhead pressure of 178 pounds per square inch. Bottom-hole pressure recorders from latest testings performed indicated a producing drawdown of approximately 30%. Additional production history is required to determine stabilized flow rates of the well. Surface facilities are in place and the well is already in production. The Tigana Norte 4 well follows the recently drilled Tigana Norte 3 and Tigana Norte 2 wells and extends and broadens the Tigana oil field towards the northeastern limits of the Llanos 34 block. The well was drilled outside the 3P reserve outline defined in the 2016 DeGolyer and MacNaughton reserves certification, to a bottom-hole location that is approximately 75 feet down dip of the Tigana Norte 1 well and did not encounter the oil-water contact.
NNVC

Hot Stocks

07:04 EDT NanoViricides initiates safety, toxicology evaluation of leading shingles drugs - NanoViricides reports that it has begun initial safety and toxicology evaluation of its optimized nanoviricides drug candidates developed against varicella-zoster virus, the shingles virus. This study is an important step in the drug development pathway for a treatment for shingles, a debilitating infection of human skin by VZV. The long term goal of this project is the development of nanoviricide drugs for topical dermal treatment of shingles, genital herpes and cold sores.
CGNT

Hot Stocks

07:02 EDT Cogentix Medical: Palmetto GBA extends Medicare coverage on Urgent PC - Cogentix Medical announced that Palmetto GBA has extended its coverage policy for Percutaneous Tibial Nerve Stimulation to allow patients with overactive bladder symptoms to receive ongoing maintenance treatments for up to three years. Patients with Medicare coverage in North Carolina, South Carolina, most of Virginia and West Virginia can continue to receive the benefits of PTNS therapy delivered by Cogentix Medical's Urgent PC Neuromodulation System for their overactive bladder symptoms for an additional year.
FRED

Hot Stocks

07:02 EDT Fred's announces review of alternatives for certain noncore assets - Fred's announced that its board of directors has cancelled its quarterly cash dividend in order to retain free cash flow for debt reductions, share repurchases and other general corporate purposes. The declaration of future cash dividends will be subject to the discretion of the Board based on a number of factors, including but not limited to, the company's financial performance, its available cash resources, capital requirements and its investment opportunities. In connection with the cancellation of the dividend the Board has amended the company's previously disclosed 2012 stock repurchase program. The amended program will allow for the repurchase of up to 3.8 million shares of the Company's outstanding Class A voting common stock. Moreover, in shifting the company's focus towards driving increased traffic, improving its gross margin, reducing SG&A, and generating free cash flow per share, the Board is considering various strategic transactions and alternatives for certain non-core assets, including real estate and the specialty pharmacy business. The decision to consider and explore these strategic alternatives is not in response to any third party proposal and no decision has been made to engage in any of these particular transactions. Michael K. Bloom, CEO of Fred's, stated, "We are excited about the progress we have made in executing our strategic turnaround plan, which followed an exhaustive and comprehensive evaluation of our business, and which has prioritized driving traffic, reducing SG&A expenses as a percentage of sales, reducing our leverage levels over time, driving profitability and generating free cash flow per share. We believe that we now are in a position to further enhance our strategic plan by exploring a variety of strategic initiatives and by investing in our common stock which we believe, given current share prices, represents an attractive use of funds and provides us an additional opportunity to build long-term value for our shareholders."
FRED

Hot Stocks

07:01 EDT Fred's board cancels quarterly dividend to retain free cash flow
WBA

Hot Stocks

07:00 EDT Walgreens Boots Alliance to invest in Chinese pharmacy chain GuoDa - Walgreens Boots Alliance announces that it has reached an agreement with China National Accord Medicines Corporation Ltd. to become an investor in its subsidiary Sinopharm Holding Guoda Drugstores Co., Ltd., which operates and franchises retail pharmacies across China. Following a public tender process, Walgreens Boots Alliance's bid met all the requirements set by the seller to acquire a 40% minority stake in GuoDa through a capital increase worth around $416M. The transaction is subject to regulatory review and approval, and other customary closing conditions. Upon completion, Walgreens Boots Alliance would account for this stake as an equity method investment.
MDGL

Hot Stocks

06:57 EDT Madrigal's MGL-3196 achieves primary endpoint in Phase 2 clinical trial - Madrigal Pharmaceuticals announced positive top-line results from a Phase 2 clinical trial in patients with biopsy-proven non-alcoholic steatohepatitis. In this trial, MGL-3196, a first-in-class, oral, once-daily, liver-directed, thyroid hormone receptor beta -selective agonist, demonstrated statistically significant results for the primary endpoint, the percent change in hepatic fat versus placebo as measured by MRI-PDFF, a non-invasive imaging test. Recent published data have shown a high correlation of the reduction of liver fat of 30% or more as measured by MRI-PDFF to improvement in NASH on liver biopsy. Statistically significant reductions in ALT and AST were observed in MGL-3196 treated patients; greater reductions in ALT and AST, statistically significant relative to placebo, were observed in the prespecified group of 44/78 patients with relatively higher MGL-3196 drug levels. In drug-treated relative to placebo patients, statistically significant improvements were also seen in multiple secondary endpoints considered to be potentially clinically relevant in patients with NASH including LDL-C, triglycerides, apolipoprotein B, and Lp(a). MGL-3196 has been well-tolerated with mostly mild AEs, and a few moderate AEs, the numbers of which are balanced between placebo and drug-treatment groups. There are no adverse effects of MGL-3196 on safety laboratory or vital sign parameters. There have been three serious adverse effects in the study, all considered unrelated to MGL-3196. The on-going study remains blinded. Safety, efficacy of NASH resolution by biopsy, and repeat MRI-PDFF will be assessed at 36 weeks. Multiple inflammatory and fibrosis serum biomarkers at 12 and 36 weeks are being and will be assessed.
AZN

Hot Stocks

06:52 EDT AstraZeneca says first data presentation of Calquence to be made at ASH meeting - AstraZeneca, along with Acerta Pharma, its hematology research and development center of excellence, and MedImmune, its global biologics research and development arm, will highlight progress in blood cancer research at the 59th 2017 American Society of Hematology Annual Meeting, the company announced. Following the FDA accelerated approval of Calquence, a kinase inhibitor indicated for the treatment of adult patients with MCL who have received at least one prior therapy, data from the pivotal Phase II ACE-LY-004 clinical trial on which the accelerated approval was based, will be presented for the first time. New details of the trial will be shared, including median time to response, pre-specified patient subgroup efficacy analyses, as well as safety analyses, further characterising the clinical profile of Calquence in this patient population. Also, results will be presented from the Phase Ib/II ACE-CL-003 trial evaluating Calquence and obinutuzumab in treatment-naive and previously-treated CLL patients, which highlight the safety profile and activity of the combination. AstraZeneca will present additional data from its hematology portfolio, including findings from a Phase I trial of moxetumomab pasudotox, an anti-CD22 recombinant immunotoxin and potential new medicine in development for the treatment of people with previously-treated HCL and early data on AZD2811, a novel nanoparticle inhibitor of aurora kinase B being tested in AM.
NBY GHDX

Hot Stocks

06:51 EDT NovaBay names Lewis Stuart as Chief Commercial Officer - NovaBay (NBY) announces the appointment of Lewis Stuart as Chief Commercial Officer. Stuart joined NovaBay on December 1 and brings more than 30 years of biopharmaceutical industry experience. At NovaBay, he will be responsible for leading all commercial activities, including driving sales and revenue growth of Avenova in new and existing markets, and expanding the company's global commercial channel. Prior to NovaBay, Stuart was Vice President, U.S. Oncology for Genomic Health (GHDX).
UNH DVA

Hot Stocks

06:49 EDT Optum to acquire DaVita Medical Group for approximately $4.9B in cash - Optum, part of UnitedHealth Group (UNH), and DaVita Medical Group, a subsidiary of DaVita (DVA), are combining. The agreement, entered into on December 5, calls for Optum to acquire DaVita Medical Group for approximately $4.9B in cash. The transaction is expected to close in 2018 and is subject to regulatory approval and other customary closing conditions. Following the transaction, DaVita Medical Group will become part of Optum's OptumCare division, which works with more than 80 health plans to serve millions of consumers annually through 30,000 affiliated physicians and hundreds of care facilities. Joe Mello, COO of DaVita Medical Group, will continue in a leadership role in the combined entity, as will the DaVita Medical Group leadership team. DaVita plans to use the proceeds from the transaction for significant stock repurchases over the one to two years following the closing of the transaction, as well as to repay debt and for general corporate purposes.
UNH DVA

Hot Stocks

06:46 EDT Optum to acquire DaVita Medical Group for approximately $4.9B in cash
SCOR FOXA

Hot Stocks

06:44 EDT comScore announces expansion agreement with Fox Networks - On Tuesday, comScore announced an agreement with the Fox Networks Group that expands its existing relationship to include linear TV ratings measurement and comScore's suite of Advanced Audiences segmentation, sourced from partnerships with best in class consumer data reporting companies. FNG's national sports channels FS1 and FS2, along with FNG's FOX, FX and National Geographic channels, will now access comScore's complete RAPAPI and Optimizer measurement insights.
TROX

Hot Stocks

06:40 EDT FTC challenges Tronox's acquisition of Cristal - The Federal Trade Commission last night issued an administrative complaint challenging Tronox's acquisition of Cristal. The FTC's administrative complaint charged that Tronox's proposed acquisition "would violate the antitrust laws by significantly reducing competition in the North American market (comprised of the United States and Canada) for chloride process titanium dioxide. The FTC alleges that the acquisition, if consummated, would increase the risk of coordinated action among the remaining competitors, and increase the risk of future anticompetitive output reductions by Tronox." The Commission added that it authorized agency staff to seek a temporary restraining order and preliminary injunction in federal court, if necessary, to maintain the status quo pending an administrative trial on the merits. Reference Link
TPIV

Hot Stocks

06:34 EDT TapImmune appoints Dr. Richard Kenney as Acting Chief Medical Officer - TapImmune announced the appointment of Richard Kenney, M.D., F.A.C.P., as Acting Chief Medical Officer. In this newly created role at TapImmune, Dr. Kenney will continue to manage the company's ongoing and planned clinical programs for its novel, multi-epitope, T-cell vaccine candidates. Dr. Kenney has served as Head of Clinical Development for TapImmune since May 2017, and served previously as Chief Medical Officer for two biotech publicly traded companies focused on developing immunotherapies for oncology and infectious disease.
CLNT

Hot Stocks

06:32 EDT Cleantech Solutions enters into conditional share swap agreement with Ever-Long - Cleantech Solutions announced that its wholly-owned subsidiary, EC Assets Management, has entered into a conditional share swap agreement with Ever-Long Holdings Limited and certain of its officers and directors, to acquire a 51% interest in the issued share capital of Brighten Holdings Int'l Limited, a subsidiary of Styland Holdings Limited, a Hong-Kong-listed company. The terms of the agreement stipulate that the Ever-Long Parties shall transfer 51% of Brighten's issued share capital, which is valued at $16.45M, based on 510,000 ordinary voting shares at a price of $32.25 per Brighten share. In exchange, the company shall issue a certain number of its shares of common stock, representing 19.5% of the issued and outstanding shares of CLNT, and a 5-year interest-free promissory note with a principal amount of $13.76M to Brighten. The agreement is subject to various conditions, including entry into a definitive agreement satisfactory to both parties and legal and financial due diligence.
DUK PYPL

Hot Stocks

06:23 EDT Duke Energy: Some customers may be affected by TIO data breach - Duke Energy Carolinas (DUK) customers who paid a bill at one of the company's 550 authorized walk-in payment processing centers between 2008 and 2017 may be affected by a potential compromise of personally identifiable information, according to PayPal Holdings (PYPL), who recently acquired TIO Networks, which is the company who owns the network used to process payments made at those locations. TIO Networks will begin notifying anyone whose information they believe may be included in the potential compromise, including approximately 374,000 Duke Energy Carolinas customers, who may be affected. The letter will come directly from TIO Networks and will include detailed questions and answers and a phone number for additional information. "This TIO Networks issue has possibly and unfortunately affected some of our customers, and we are doing all we can to help," said Lesley Quick, Duke Energy's vice president of revenue services. "We have remained in daily contact with our vendor since they abruptly and unexpectedly disabled their network on Nov. 10 for suspected "security vulnerabilities." This issue only affects customers who paid by check or cash at an authorized walk-in payment processing center, and not customers who paid via credit card or another form of payment. The personally identifiable information that may have been compromised includes, name, address, Duke Energy account number and balance, and banking information, if a customer paid by check.
UMC MU

Hot Stocks

06:20 EDT UMC says sued by Micron over trade secret infringement - In a regulatory filing, UMC (UMC) says Micron Technology (MU) filed a civil lawsuit in California accusing UMC of DRAM trade secret infringement. UMC will appoint legal counsel to protect the interests and goodwill of UMC. UMC respects the intellectual property owned by all others, and will not violate their rights. UMC invested resources in the R&D of semiconductor technologies and owns numerous related patents. UMC will protect the company's interests in due course under the law.
MYOS

Hot Stocks

06:12 EDT MYOS RENS enters research agreement with University of California, Berkeley - MYOS RENS Technology has entered into a research agreement with the University of California, Berkeley's Department of Nutritional Sciences & Toxicology. The study will look into the effects of Fortetropin on increasing the fractional rate of skeletal muscle protein synthesis in men and women between 60 and 75 years old. Fortetropin, owned by MYOS RENS, a bionutrition company, is a natural food product that helps build lean muscle in conjunction with resistance training. The Principal Investigator for this clinical study will be William J. Evans, PhD, Adjunct Professor of Human Nutrition at the Department of Nutritional Sciences & Toxicology at the University of California, Berkeley campus. Professor Evans, a leading authority in muscle health research, will coordinate the activities of a multi-disciplinary team of scientists and physicians.
T

Hot Stocks

06:06 EDT AT&T: DirecTV Now has surpassed 1M subscribers - The AT&T over-the-top streaming service, DIRECTV NOW, "has officially surpassed 1 million subscribers while celebrating our first year. We listened when customers said they wanted more flexible TV options. And DIRECTV NOW set out to bring TV lovers a new way to experience their favorite shows virtually anywhere at a great price... We're putting some finishing touches on more features in beta testing we plan to roll out on our next generation video platform over the coming months. These include a DVR in the cloud to record shows and access virtually anywhere, 4K Ultra High Definition quality video, capacity for more than 35,000 OnDemand titles, individual profiles and an even better user experience." Reference Link
HD

Hot Stocks

06:05 EDT Home Depot announces new $15B share repurchase program - Home Depot announced a $15B share repurchase program, replacing its previous authorization.
HD

Hot Stocks

06:04 EDT Home Depot announces new $15B share repurchase program
TAC

Hot Stocks

06:03 EDT TransAlta, Tidewater Midstream announce LOI to construct pipeline - TransAlta and Tidewater Midstream announced that the two companies have entered into a Letter of Intent, or LOI, for Tidewater to construct a 120 Kilometre natural gas pipeline from its Brazeau River Complex to TransAlta's generating units at Sundance and Keephills. The Tidewater Pipeline will facilitate TransAlta's strategy to convert its coal units at Sundance and Keephills to natural gas. Converting the coal units extends the operating life of the assets and significantly reduces operating costs and emissions. The pipeline will provide initial capacity of 130 MMcf/d by 2020, and have expansion capability to 340 MMcf/d, which represents approximately 50% of TransAlta's gas requirements at full capacity. Under the LOI, TransAlta has the option to invest up to 50% in the pipeline.
SQ BITCOIN

Hot Stocks

06:00 EDT Square's Cash App says rolling out bitcoin to more active customers - Square's Cash App tweeted: "Blockchaiiiiinnnnn. We're rolling out bitcoin to more of our most active customers. Swipe right from your Cash Card to see if you have it. #satoshi." Reference Link
ESLT

Hot Stocks

05:44 EDT Elbit Systems to provide, operate simulators for IAF transport aircraft - Elbit Systems announced that it was selected by the Israeli Ministry of Defense to provide and operate flight simulators for the upgraded C-130H and C-130J transport aircraft of the Israeli Air Force, or IAF. The contract value will be in an amount of $74M for a thirteen-year period which includes a set up phase of approximately three years and a ten-year operating period. Elbit Systems will set up and operate the IAF upgraded C-130H and C-130J training center, providing two inter-connected flight simulators that enable both single and squadron training and a ground crews simulator that enables high fidelity training of aircraft maintenance procedures.
HY

Hot Stocks

05:31 EDT Hyster-Yale Materials agrees to acquire controlling interest in Zhejiang Maximal - Hyster-Yale Materials Handling announced today that it has entered into a definitive agreement to acquire, through an indirect wholly-owned subsidiary, 75% of the outstanding shares of, and a controlling interest in, Zhejiang Maximal Forklift Company Limited from KNSN Pipe and Pile Company Limited for an aggregate purchase price of $90 million, funded using Hyster-Yale's cash on hand. The remaining 25 percent share of the new company, which will be named Hyster-Yale Maximal Materials Handling, will be owned by current Zhejiang Maximal Forklift senior management through Y-C Hong Kong Holding Company. The proposed transaction is a strategic action that is expected to expand the Company's low-cost, global manufacturing capabilities, develop access to competitive component sourcing, further strengthen Hyster-Yale's utility and standard product portfolio by adding a wider spectrum of products to an already leading global materials handling business, and enhance the Company's presence in both the China market, as well as in the growing global utility and standard market segments. Although Hyster-Yale has been in the China market for a number of years, the company's market share has been limited and focused in the more premium segments. Maximal has achieved success in the utility and standard segments in this region, and this joint venture will allow Hyster-Yale to start reaching this expanded customer base. This is especially important for strengthening Hyster-Yale's current China operations, which are operating on a scale below the level needed for long-term success. For the year ended December 31, 2016, Maximal had revenues of 482.63 RMB or approximately $66.3 million, with domestic and export volume of nearly 6,000 units. Bookings and revenues in 2017 have increased nearly 20% over 2016. Due to the investments that Hyster-Yale intends to make in the joint venture, the proposed acquisition, while currently profitable, is expected to be dilutive to the company's earnings in 2018 by $5M to $10M pre-tax due to additional investments in expense and capital needed to implement the company's integration plan. The acquisition is expected to move toward being accretive in the medium term under conservative market share and synergy objectives. The closing of the transaction, which is expected to take place during the first half of 2018, is subject to customary closing conditions and required regulatory approvals.
TROX

Hot Stocks

05:18 EDT Tronox announces intent to fight FTC lawsuit - Tronox said it would vigorously fight a lawsuit filed December 5, by the U.S. Federal Trade Commission, or FTC, seeking to block the company's proposed acquisition of the titanium dioxide, or TiO2, business of Cristal, a privately held global chemical and mining company headquartered in Jeddah, Saudi Arabia. Tronox maintains that the FTC's complaint is based on an erroneous view of the global TiO2 market and a flawed analysis of the Tronox/Cristal transaction. "It is extremely disappointing that the FTC has taken this unmerited action to try to block a highly synergistic acquisition which will enhance competition in the TiO2 industry and benefit our customers around the world," said Tronox CEO Jeffry Quinn. "Our combination with Cristal is an important part of our strategy to build a vertically integrated company that will deliver a low-cost, secure supply of TiO2 pigment to a global customer base." Quinn stated: "The FTC bears the burden of proving to a court that this transaction violates the law. While we are always willing to consider appropriate remedial action to address the commission's concerns, we maintain the transaction should be allowed to proceed and are fully prepared to defend our position in court."
RBA

Hot Stocks

05:15 EDT Ritchie Bros. apparent high bidder for DoD non-rolling stock surplus contracts - For the past three years, Ritchie Bros.' GovPlanet marketplace has been helping the U.S. Department of Defense's Defense Logistics Agency, or DLA, sell thousands of its surplus rolling stock assets. Today, Ritchie Bros. is expanding its relationship with the government agency, after being declared apparent high bidder for two new contracts with the DLA, to purchase, manage and sell non-rolling stock surplus assets for both its East and West regions. The contract has a base term of two years with four one-year renewal options. Non-rolling stock assets include non-wheeled items such as industrial machinery, electrical equipment, textiles, spare parts and other miscellaneous surplus assets.